<!DOCTYPE html>

<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]>      <html class="no-js"> <![endif]-->

<!--[if gt IE 8]><!-->
<html class="no-js" prefix="og: http://ogp.me/ns#">
<!--<![endif]-->

<head>
<title>Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714</title>
<meta http-equiv="content-type" content="text/html; charset=UTF-8" />
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />

<meta name="citation_doi" content="10.3892/ijo.2012.1617" />
<meta name="citation_journal_title" content="International Journal of Oncology" />
<meta name="citation_title" content="Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714" />

	<meta name="citation_author" content="Li,Bo " />
	<meta name="citation_author_institution" content="Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200092, P.R. China" />

	<meta name="citation_author" content="Yang,Yuehua " />
	<meta name="citation_author_institution" content="Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200092, P.R. China" />

	<meta name="citation_author" content="Jiang,Shengdan " />
	<meta name="citation_author_institution" content="Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200092, P.R. China" />

	<meta name="citation_author" content="Ni,Binbin " />
	<meta name="citation_author_institution" content="Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200092, P.R. China" />

	<meta name="citation_author" content="Chen,Ke " />
	<meta name="citation_author_institution" content="Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200092, P.R. China" />

	<meta name="citation_author" content="Jiang,Leisheng " />
	<meta name="citation_author_institution" content="Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200092, P.R. China" />


<meta name="citation_publication_date"
	content="2012-11-01" />
<meta name="citation_volume" content="41" />
<meta name="citation_issue" content="5" />
<meta name="citation_firstpage" content="1809" />
<meta name="citation_lastpage" content="1819" />
<meta name="citation_publisher" content="Spandidos Publications" />
<meta name="citation_issn" content="1019-6439" />
<meta name="citation_abstract_html_url" content="http://www.spandidos-publications.com/10.3892/ijo.2012.1617/abstract" />
<meta name="citation_pdf_url" content="http://www.spandidos-publications.com/10.3892/ijo.2012.1617/download" />
<meta name="citation_fulltext_world_readable" content="" />

<meta name="keywords"
	content="cancer, oncology, oncogene, molecular medicine, tumor, apoptosis, gene, cell, research, scientific journals, tumour suppressor genes, cell cycle, growth factors" />
<meta name="verify-v1"
	content="qIInQfvSmbVNPO1nn+hEr0GnchYI4j93np2wrWGr29A="></meta>
<meta name="verify-v1"
	content="KOd/fzGN2I+RDbonO/qYB3yaji9QcOddBCxBKx+5j9U="></meta>
	
	
 <meta name="twitter:card" content="summary"></meta>
 <meta name="twitter:title" content="Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714"></meta>
 <meta name="twitter:site" content="https://www.spandidos-publications.com/10.3892/ijo.2012.1617"  />
 <meta name="twitter:image" content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>	
 <meta name="twitter:description" content="Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily of signaling molecules and have previously been shown to be associated with the biological behavior of osteosarcoma. However, to date the effects and molecular mechanisms of BMP-9 on osteosarcoma progression are unknown. We performed real-time PCR and western blot analysis to characterize the endogenous expression of BMP-9 in osteosarcoma cell lines. We used a recombinant adenovirus expressing BMP-9 (adBMP-9) to infect osteosarcoma cell lines with relatively low endogenous BMP-9 expression to determine the functional relevance of BMP-9 overexpression to osteosarcoma cell growth and migration in vitro and in vivo, and further investigated the expression levels of Ki-67, matrix metallopeptidase-9 (MMP-9), phosphoinositide 3-kinase p85α (PI3Kp85α) and phosphorylated AKT (p-AKT). As a result, osteosarcoma cell proliferation and migration were significantly diminished by adBMP-9, indicated by MTT and wound-healing assays, and cell apoptosis was markedly induced, indicated by Hoechst 33342/PI assay and Annexin V-FITC apoptosis detection. When BMP-9 expression was enhanced, the expression of PI3Kp85α, p-AKT, Ki-67 and MMP-9 was downregulated in osteosarcoma cells. In addition, the tumor volumes in MG-63 and HOS subcutaneous nude mouse models treated with adBMP-9 were significantly smaller compared to those of the ad-GFP group. These results suggested that the enhanced expression of BMP-9 in osteosarcoma cells by adBMP-9 exerted inhibitory effects on growth and migration of osteosarcoma cells possibly via blockade of the PI3K/AKT signaling pathway."/>	
 

 <meta property='og:title' content="Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714"/>
 <meta property='og:image:secure_url' content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>
 <meta name="image" property='og:image' content="https://www.spandidos-publications.com/resources/images/ijo.jpg"/>
 <meta property="og:image:width" content="200" /> 
 <meta property="og:image:height" content="200" />
 <meta property="og:image:type" content="image/jpg" />
 <meta property='og:description' content="Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily of signaling molecules and have previously been shown to be associated with the biological behavior of osteosarcoma. However, to date the effects and molecular mechanisms of BMP-9 on osteosarcoma progression are unknown. We performed real-time PCR and western blot analysis to characterize the endogenous expression of BMP-9 in osteosarcoma cell lines. We used a recombinant adenovirus expressing BMP-9 (adBMP-9) to infect osteosarcoma cell lines with relatively low endogenous BMP-9 expression to determine the functional relevance of BMP-9 overexpression to osteosarcoma cell growth and migration in vitro and in vivo, and further investigated the expression levels of Ki-67, matrix metallopeptidase-9 (MMP-9), phosphoinositide 3-kinase p85α (PI3Kp85α) and phosphorylated AKT (p-AKT). As a result, osteosarcoma cell proliferation and migration were significantly diminished by adBMP-9, indicated by MTT and wound-healing assays, and cell apoptosis was markedly induced, indicated by Hoechst 33342/PI assay and Annexin V-FITC apoptosis detection. When BMP-9 expression was enhanced, the expression of PI3Kp85α, p-AKT, Ki-67 and MMP-9 was downregulated in osteosarcoma cells. In addition, the tumor volumes in MG-63 and HOS subcutaneous nude mouse models treated with adBMP-9 were significantly smaller compared to those of the ad-GFP group. These results suggested that the enhanced expression of BMP-9 in osteosarcoma cells by adBMP-9 exerted inhibitory effects on growth and migration of osteosarcoma cells possibly via blockade of the PI3K/AKT signaling pathway."/>	
 <meta property='og:url' content="https://www.spandidos-publications.com/10.3892/ijo.2012.1617"/>

<link rel="stylesheet" type="text/css" media="all"
	href="/resources/css/styles.css" />
<link rel="stylesheet" href="/resources/css/jquery.fancybox.css"
	type="text/css" />

<!--[if IE 7]>  <link rel="stylesheet" type="text/css" href="/resources/css/ie7.css"> <![endif]-->
<script src="/resources/js/modernizr-3.3.1.min.js"
	type="text/javascript"></script>

</head>

<body class="ijo">

	<!--[if lt IE 7]>
        <p class="chromeframe">You are using an outdated browser. <a href="http://browsehappy.com/">Upgrade your browser today</a> or <a href="http://www.google.com/chromeframe/?redirect=true">install Google Chrome Frame</a> to better experience this site.</p>
    <![endif]-->

	
	
	<div class="wrapper">

		<div>
		<div class="super wide d-flex pb-4">
			<div class="super fixed_width">
				<ul  >
					<li><a href="/home">Home</a></li>
					
					
					<li><a href="/osats">Submit Manuscript</a></li>
					<!-- <th:block th:if="${session != null and session.user != null and session.user.type == 'user'}"> 
						<li th:if="${session.user.maxYearlyReviews} gt 0" ><a href="/reviews">Reviews</a></li>
					</th:block> -->
					<li><a href="/myaccount">My Account</a></li>
				</ul>			
			</div>
		</div>
	
		<div class="header wide">
			<div class="header fixed_width">
				<div class="header_logo">
					<a href="/home"><img src="/resources/images/spandidoslogo.png"/></a>
				</div>

				<div class="header_search">

					<div id="searchbtn">
						<a href="/advancedsearch/ijo">Advanced Search</a>
						
					</div>
					
					<div  class="searchbox">
							
							<a href="javascript:BasicSearch(&#39;ijo&#39;)"   ><img  src="/resources/images/searchbutton.png"/></a>
							
							<input class="" type="text" id= "searchFor" />		
					</div>
					
					<div> 
						
						
						<ul >
							<li><a href="/register">Register</a></li>
							<li><a href="/login" id="loginLink">Login</a></li>							
						</ul>
						
						
						
					</div>		
					
					
					
				</div>
				<div class="header_nav">
					<ul>
						<li style="width: 8.3%;" class="ol"><a href="/ol">Oncology <br />Letters</a></li>
						<li style="width: 8.3%;" class="ijo"><a href="/ijo">International <br />Journal <br />of Oncology</a></li>
						<li style="width: 8.3%;" class="mco"><a href="/mco">Molecular <br />and Clinical <br />Oncology</a></li>
						<li style="width: 8.3%;" class="etm"><a href="/etm">Experimental <br />and Therapeutic <br />Medicine</a></li>
						<li style="width: 8.3%;" class="ijmm"><a href="/ijmm">International <br />Journal <br />of Molecular <br />Medicine</a></li>
						<li style="width: 8.3%;" class="br"><a href="/br">Biomedical <br />Reports</a></li>
						<li style="width: 8.3%;" class="or"><a href="/or">Oncology <br />Reports</a></li>
						<li style="width: 8.3%;" class="mmr"><a href="/mmr">Molecular <br />Medicine <br />Reports</a></li>						
						<li style="width: 8.3%;" class="wasj"><a  href="/wasj">World Academy <br />of Sciences <br />Journal</a></li>
						<li style="width: 8.3%;" class="ijfn"><a  href="/ijfn">International <br />Journal <br />of Functional<br />Nutrition</a></li>
						<li style="width: 8.3%;" class="ije"><a  href="/ije">International <br />Journal <br />of Epigenetics</a></li>
						<li style="width: 8.3%;" class="mi"><a  href="/mi">Medicine <br />International </a></li>
					</ul>
				</div>                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
			</div>
		</div>
		
		<!-- Journal and Article pages show Journal banner -->
		<div class="banner wide flex">
			<div class="banner fixed_width">
				
				<h1>International<br/>Journal of<br />Oncology</h1>
				
				
				
				
				
				
				
				
				
				
				<img src="/resources/images/bannerijo.jpg" alt="Journal Banner" />
			</div>
		</div>		
	</div>

		<div class="content wide">
			<div class="content fixed_width">
				<div class="content_sidebar">
				<ul class="sidebar_journal_top">
					<li class="sidebar_title"><a href="/ijo">Journal Home</a></li>
					<li >
						<a href="/ijo">Current Issue</a>
					</li>
					<li>
						
						<a href="/ijo/forthcoming">Forthcoming Issue</a>
					</li>
					<li>
						<a id="toggleSpecialIssue" href="#" onclick="$('.toggleSpecialIssue').toggle();return false;">Special Issues</a>
						<ul class="toggleSpecialIssue" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/specialIssues/open">Open Special Issues</a></li>
							
							<li><a href="/pages/ijo/specialissues">About Special Issues</a></li>
							<li><a href="/osats">Submit Paper</a></li>
						</ul>
					</li>
					
					<li><a href="/ijo/mostread">Most Read</a></li>
					<li>
						<a id="toggleMostCitedDimensions" href="#" onclick="return false">Most Cited (Dimensions)</a>
						<ul class="toggleMostCitedDimensions" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/mostciteddimensionrecent">Past Two Years</a></li>
							<li><a href="/ijo/mostciteddimension">Total</a></li>
						</ul>
					</li>
					<li><a id="toggleMostCitedCrossRef" href="#" onclick="return false">Most Cited (CrossRef)</a>
						<ul class="toggleMostCitedCrossRef" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a href="/ijo/mostcitedbylastyear">Past Year <span  class="rightsReservedCrossref">0 </span></a></li>
							<li><a href="/ijo/mostcitedby">Total</a></li>
						</ul>
					</li>
					<li><a id="toggleSM" href="#toggleSM" onclick="return false">Social Media</a>
						<ul class="toggleSM" style="display:none; margin-bottom: 0px; border:0px ">
							<li><a class="medium" href="/ijo/1m/mostaltmetricmentions">Past Month</a></li>
							<li><a class="medium" href="/ijo/1y/mostaltmetricmentions">Past Year</a></li>
							<li><a class="medium" href="/ijo/at/mostaltmetricmentions">Total</a></li>
						</ul>
					</li>
					 <li><a href="/ijo/archive">Archive</a></li>
				</ul>
				<ul class="sidebar_journal_bottom">
					<li class="sidebar_title">Information</li>
					<li><a href="/osats">Online Submission</a></li>
					<li><a href="/pages/ijo/info_for_authors">Information for Authors</a></li>
					<li><a href="/languageediting">Language Editing</a></li>
					<li><a href="/pages/info_for_reviewers">Information for Reviewers</a></li>
					<li><a href="/pages/ijo/editorialPol">Editorial Policies</a></li>
					
					<li>
						
						<a href="/pages/ijo/editorial">Editorial Academy</a>
						
					</li>
					<li>
						
						<a href="/pages/join_editorial">Join Editorial Academy</a>
						
					</li>
					
					<li><a href="/pages/ijo/aims_scope">Aims and Scope</a></li>
					<li><a href="/pages/ijo/abstracting" id="abstracting" class="staticContent">Abstracting and Indexing</a></li>
					<li><a href="/pages/ijo/bibliographic">Bibliographic Information</a></li>
					<li><a href="/pages/info_for_librarians">Information for Librarians</a></li>
					<li><a href="/pages/info_for_advertisers">Information for Advertisers</a></li>	
					<li><a href="/pages/reprints">Reprints and permissions</a></li>						
					<li><a href="/pages/ijo/contact">Contact the Editor</a></li>
				</ul>
				
				<ul class="sidebar_journal_bottom">
						<li class="sidebar_title">General Information</li>
						<li><a href="/pages/about">About Spandidos</a></li>
						<li><a href="/pages/conference">Conferences</a></li>
						<li><a href="/pages/jobs">Job Opportunities</a></li>
						<li><a href="/pages/contact">Contact</a></li>
						<li><a href="/pages/terms">Terms and Conditions</a></li>
				 </ul>	
			</div>

				<div class="content_main">
					<div class="content_article">
					
					
						

						

						
							<h1>Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway </h1>
							
							<h2>
								<span class="red">Corrigendum in:</span> <a href="/10.3892/ijo.2016.3714">/10.3892/ijo.2016.3714</a>
							</h2>
							
							
														
							
						

						

						

						<ul class="article_details">
						
						    
						
							<li><span class="bold">Authors:</span>
								<ul id="authorshipNames">
									
										
										<li>Bo  Li</li>
									
										
										<li>Yuehua  Yang</li>
									
										
										<li>Shengdan  Jiang</li>
									
										
										<li>Binbin  Ni</li>
									
										
										<li>Ke  Chen</li>
									
										
											
												<li class="corresponding"
													title="jiangleisheng@126.com">Leisheng  Jiang</li>
											
										
										
									
								</ul>
							</li>

							<li><p>
									<a class="bold" href="#" id="toggle">View Affiliations</a>
								</p>

								<div class="toggle" style="display: none;">
									<br /> <span class="bold">Affiliations: </span><span>Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200092, P.R. China</span>
								</div></li>

							<!--<li><span class="bold">Corresponding author:</span> <span th:text="${dispArt.correspondingList}">Author name</span></li>-->
							<li><span class="bold">Published online on:</span> <span
								id="publishedOn">September 4, 2012</span> <span>&nbsp;&nbsp;&nbsp;</span> <span
								id="doi">https://doi.org/10.3892/ijo.2012.1617</span>
							</li>

							<li>
								
									<span  class="bold">Pages: </span>
									<span>1809-1819</span>
								
								
								
								</li>

							
						</ul>



						<div>

							<div id="metrics">
								<div>
									<span title="The metrics are calculated only from this site"
										class="bold">Metrics: </span> <span class="small"
										title="The metrics are calculated only from this site">Total
										Views: </span> <span
										title="The metrics are calculated only from this site"
										class="bold small" id="postTotalFullArticleViews">0 </span> <span
										class="small">(Spandidos Publications:</span> <span
										class="bold small" id="postFullArticleViews"></span> <span
										class="small"> | PMC Statistics: </span> <span
										class="bold small" id="postPMCFullArticleViews"></span> <span
										class="small">)</span>

									<div>
										<span style="visibility: hidden;"
											title="The metrics are calculated only from this site"
											class="bold">Metrics: </span> <span
											title="The metrics are calculated only from this site"
											class="small">Total PDF Downloads: </span> <span
											title="The metrics are calculated only from this site"
											id="postTotalArticleDownloads" class="bold small">0 </span> <span
											class="small">(Spandidos Publications:</span> <span
											class="bold small" id="postArticleDownloads"></span> <span
											class="small"> | PMC Statistics: </span> <span
											class="bold small" id="postArticlePMCDownloads"></span> <span
											class="small">)</span>
									</div>

								</div>



							</div>
							<div>
								<span id="citationCountId"> <a class="citedByCountId"
									style="margin-left: 0px"
									href="/getTotalCount/10.3892/ijo.2012.1617"></a>
								</span>
								<span id="citation"> <a class="citedBy"
									style="margin-left: 0px"
									href="/citationhtml/10.3892/ijo.2012.1617/html">
										Cited By (CrossRef): </a>
								</span> <span class="bold small" id="citationCount">0</span> <span
									class="bold small"> citations </span>
								<span class="bold small citationAllArticlesClass" id="citationAllArticlesId">
									<a id="citedByIdViewArticles" class="citedBy"
									style="font-size: 15px; text-decoration: none; margin-left: 0px"
									href="/citationhtml/10.3892/ijo.2012.1617/html">
										Loading Articles... </a>
								</span> 
							</div>

							<a class="moreLikeThis" style="display: none"
								href="/morelikethis/23420"></a>

							<div id="citationDiv" style="display: none">
								<h4>This article is mentioned in:</h4>
								<div id="citations"></div>
							</div>

							<span class="__dimensions_badge_embed__"
								data-hide-zero-citations="true" data-legend="always"
								data-style="small_circle" data-doi="10.3892/ijo.2012.1617"></span>
							<script async="async" src="https://badge.dimensions.ai/badge.js"
								charset="utf-8"></script>
							<br></br> <span data-hide-no-mentions="true"
								data-badge-details="right" class='altmetric-embed'
								data-badge-type="donut" data-link-target="_blank" data-doi="10.3892/ijo.2012.1617"></span>
						</div>


						<h4>Abstract</h4>

						


						<div
							id = "articleAbstract">Bone morphogenetic proteins (BMPs) are members of the TGF-β superfamily of signaling molecules and have previously been shown to be associated with the biological behavior of osteosarcoma. However, to date the effects and molecular mechanisms of BMP-9 on osteosarcoma progression are unknown. We performed real-time PCR and western blot analysis to characterize the endogenous expression of BMP-9 in osteosarcoma cell lines. We used a recombinant adenovirus expressing BMP-9 (adBMP-9) to infect osteosarcoma cell lines with relatively low endogenous BMP-9 expression to determine the functional relevance of BMP-9 overexpression to osteosarcoma cell growth and migration in vitro and in vivo, and further investigated the expression levels of Ki-67, matrix metallopeptidase-9 (MMP-9), phosphoinositide 3-kinase p85α (PI3Kp85α) and phosphorylated AKT (p-AKT). As a result, osteosarcoma cell proliferation and migration were significantly diminished by adBMP-9, indicated by MTT and wound-healing assays, and cell apoptosis was markedly induced, indicated by Hoechst 33342/PI assay and Annexin V-FITC apoptosis detection. When BMP-9 expression was enhanced, the expression of PI3Kp85α, p-AKT, Ki-67 and MMP-9 was downregulated in osteosarcoma cells. In addition, the tumor volumes in MG-63 and HOS subcutaneous nude mouse models treated with adBMP-9 were significantly smaller compared to those of the ad-GFP group. These results suggested that the enhanced expression of BMP-9 in osteosarcoma cells by adBMP-9 exerted inhibitory effects on growth and migration of osteosarcoma cells possibly via blockade of the PI3K/AKT signaling pathway.</div>

						<div>
							<div>



<h4>Introduction</h4>
<p>Osteosarcoma is the most common primary malignant
bone tumor, accounting for approximately 20% of all primary
sarcomas in bone. Although treatment modalities have been improved
over the past decades, it is still a tumor with a high mortality
rate ascribed to tumor cell invasion and metastasis (<a href="#b1-ijo-41-05-1809" class="linksColor">1</a>). Bone morphogenetic proteins (BMPs), a
group of the most powerful bone inductive factors enriched in the
bone matrix, have been indicated in osteosarcoma and its
metastasis.</p>
<p>BMP belongs to the transforming growth factor-β
super-family. BMP signaling in diseases is the subject of a large
quantity of studies, and has already been shown to play a vital
role in the development and progression of cancer (<a href="#b2-ijo-41-05-1809" class="linksColor">2</a>,<a href="#b3-ijo-41-05-1809" class="linksColor">3</a>). The
presence of BMPs in osteosarcoma has been verified and the role of
BMPs in osteosarcoma has also been widely investigated. Studies
demonstrated that seven BMPs (BMP 2-8) and all their receptors were
simultaneously expressed in osteosarcoma cells (<a href="#b4-ijo-41-05-1809" class="linksColor">4</a>) and osteosarcomas producing BMPs
contained less-differentiated mesenchymal cells, resulting in a
poorer prognosis for those patients (<a href="#b5-ijo-41-05-1809" class="linksColor">5</a>). BMP 2–8 were all expressed in
osteosarcomas, of which BMP 6–8 were highly expressed and BMP-6
correlated with a chondroid differentiation (<a href="#b6-ijo-41-05-1809" class="linksColor">6</a>). BMP-2 promoted migration of
osteosarcom cells by enhancing incorporation of integrin-β
(<a href="#b7-ijo-41-05-1809" class="linksColor">7</a>), and may be an important
factor in the metastasis of osteosarcoma. A recent study indicated
that inhibition of BMPs could be investigated as a possible
strategy for decreasing the incidence of pulmonary metastases in
osteosarcoma (<a href="#b8-ijo-41-05-1809" class="linksColor">8</a>).</p>
<p>BMP-9 has been shown as a pleiotropic cytokine,
which is implicated in a number of physiologic events. These
include bone morphogenesis, functions of hepatic
reticuloendothelial system, hematopoiesis, neuronal
differentiation, glucose homeostasis, iron homeostasis, and
angiogenesis (<a href="#b9-ijo-41-05-1809" class="linksColor">9</a>–<a href="#b15-ijo-41-05-1809" class="linksColor">15</a>). Although the expression of BMP-9 was
initially thought to be restricted to the liver, it has been shown
that BMP-9 binds with high affinity to activin receptor-like kinase
1 (ALK1) and endoglin in endothelial cells, and induces
phosphorylation of Smad-1/5/8 (<a href="#b16-ijo-41-05-1809" class="linksColor">16</a>). This signaling inhibits basic
fibroblast growth factor-stimulated proliferation and migration of
bovine aortic endothelial cells and VEGF-induced angiogenesis
(<a href="#b17-ijo-41-05-1809" class="linksColor">17</a>). BMP-9 also inhibits the
migration and growth of human dermal microvascular endothelial
cells (<a href="#b15-ijo-41-05-1809" class="linksColor">15</a>) and the DNA synthesis
of human aortic endothelial cells via ALK-1 (<a href="#b18-ijo-41-05-1809" class="linksColor">18</a>). BMP-9 has been reported to induce
apoptosis in prostate cancer cells and prevent the migration and
invasiveness of prostate cancer (<a href="#b19-ijo-41-05-1809" class="linksColor">19</a>). However, the roles played by this
cytokine in osteosarcoma have not been explored. In the present
study, the endogenous expression of BMP-9 was examined in
osteosarcoma cell lines. The biological function of this molecule
was investigated in cells that overexpress this molecule in order
to establish the functional role of BMP-9 in osteosarcoma cells.
Finally, the underlying signaling pathway involved in the
progression of osteosarcoma was explored.</p>


<h4>Materials and methods</h4>

<h5>Materials</h5>
<p>MG-63, U-2 and HOS osteosarcoma cell lines used in
the experiment were from Institute of Biochemistry and Cell Biology
(Shanghai, China). Fifteen 6-week-old female immune-deficient nude
mice (BALB/c-nu) were purchased from Shanghai SLAC Laboratory
Animal Co. Ltd (Shanghai, China). AdBMP-9 adenovirus vector,
negative control vector ad-GFP and virion-packaging elements were
from Genechem (Shanghai, China). The primers of BMP-9, PI3Kp85α and
p-AKT, GAPDH, were synthesized by ABI Co. Ltd (USA). All antibodies
were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).</p>


<h5>Drugs and reagents</h5>
<p>
3-(4,5)-Dimethylthiahiazo(-z-yl)-3,5-diphenyltetrazolium bromide
(MTT) was from Dingguo biology (Shanghai, China); Dulbecco’s
modified Eagle’s medium (DMEM) and fetal bovine serum (FBS) were
from Thermo Fisher Scientific Inc. (Waltham, MA, USA); TRIzol
Reagent and Lipofectamine 2000 were from Invitrogen (Carlsbad, CA,
USA); M-MLV Reverse Transcriptase was from Promega (Madison, WI,
USA); SYBR-Green Master mixture was from Takara (Otsu, Japan);
RNase A and double stain apoptosis detection kit (Hoechst 33342/PI)
were from Roche Diagnostics (Mannheim, Germany) and Annexin V-FITC
apoptosis detection kit I from BD Pharmingen (San Diego, CA, USA).
ECL-PLUS/Kit was from GE Healthcare (Piscataway, NJ, USA).</p>


<h5>Cell culture and adenovirus
transfection</h5>
<p>MG-63 and HOS osteosarcoma cell lines were cultured
in DMEM medium supplemented with 10% heat-inactivated FBS, 100 U/ml
of penicillin and 100 μg/ml of streptomycin. They were all placed
in a humidified atmosphere containing 5% CO<span class="subscript">2</span> at 37°C.
Recombinant adenovirus vector adBMP-9 and negative control ad-GFP
were transfected into MG-63 and HOS osteosarcoma cell lines. Cells
were subcultured at a 1:5 dilution in 300 μg/ml G418-containing
medium. Positive stable transfectants were selected and expanded
for further study. The clone in which the adBMP-9 adenovirus
vectors were transfected was named as adBMP-9 group, the negative
control vectors as the ad-GFP group and MG-63 or HOS osteosarcoma
cells without gene transfection as the CON group.</p>


<h5>Real-time PCR</h5>
<p>To quantitatively determine the mRNA expression
levels of BMP-9, PI3Kp85α and p-AKT in osteosarcoma cell lines,
real-time PCR was used. Total-RNA of each clone was extracted with
TRIzol according to the manufacturer’s protocol.
Reverse-transcription was carried out using M-MLV and cDNA
amplification was carried out using SYBR-Green Master mix kit
according to the manufacturer’s protocol. The genes were amplified
using specific oligonucleotide primer and human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as
an endogenous control. The PCR primer sequences were as follows:
BMP-9, 5′-TTCCTTCAGAGC AAACAGCA-3′ and 5′-GTTGTGCTCAAATCCCCATT-3′;
PI3Kp85α, 5′-GAAAGGAGGAAAUAACAAAdtdt-3′ and
5′-UUUGUUAUUUCCUCCUUUCdtdt-3′; p-AKT, 5′-GGAG
AUCAUGCAGCAUCGCdtdt-3′ and 5′-GCGAUGCUGCA UGAUCUCCdtdt-3′; GAPDH,
5′-CAACGAATTTGGCTAC AGCA-3′ and 5′-AGGGGTCTACATGGCAACTG-3′. Data
were analyzed using the comparative Ct method (2<span class="superscript">−ΔΔCt</span>).
Three separate experiments were performed for each clone.</p>


<h5>Western blot assay</h5>
<p>Osteosarcoma cells were harvested and extracted
using lysis buffer (Tris-HCl, SDS, mercaptoethanol, glycerol). Cell
extracts were boiled for 5 min in loading buffer and then equal
amount of cell extracts were separated on 15% SDS-PAGE gels.
Separated protein bands were transferred into polyvinylidene
fluoride (PVDF) membranes and the membranes were blocked in 5% skim
milk powder. The primary antibodies against BMP-9, PI3Kp85α, p-AKT,
Ki-67 and MMP-9 were diluted according to the instructions of
antibodies and incubated overnight at 4°C. Then, horseradish
peroxidase-linked secondary antibodies were added at a dilution
ratio of 1:1,000 and incubated at room temperature for 2 h. The
membranes were washed with PBS three times and the immunoreactive
bands were visualized using ECL-PLUS/Kit according to the kit
instructions. The relative protein level in different cell lines
was normalized to GAPDH concentration. Three separate experiments
were performed for each clone.</p>


<h5>Cell proliferation assay</h5>
<p>Cell proliferation was analyzed with the MTT assay.
Briefly, cells infected with AdBMP-9 were incubated in 96-well
plates at a density of 1×10<span class="superscript">5</span> cells per well with DEME
medium supplemented with 10% FBS. Cells were treated with 20 μl MTT
dye at 0, 24, 48, 72 h and then incubated with 150 μl of DMSO for 5
min. The color reaction was measured at 570 nm with enzyme
immunoassay analyzer (Bio-Rad, Hercules, CA, USA). The
proliferative activities were calculated for each clone.</p>


<h5>Wound-healing assay</h5>
<p>MG-63 and HOS osteosarcoma cells were plated in each
well of a 6-well culture plate and allowed to grow to 90%
confluence. Treatment with adBMP-9 was then performed. The next
day, a wound was created using a micropipette tip. The migration of
cells towards the wound was monitored daily, and images were
captured at time intervals of 24 h.</p>


<h5>Hoechst 33342/PI assay</h5>
<p>This assay was performed according to a combination
of methods with modifications as detailed: 50 μl/well of a 200
μg/ml PI stock and 2.5 μl of a 100 μg/ml Hoechst 33342 was added to
a microtitre plate volume of 100 μl and incubated in the dark for
60 and 15 min, respectively. A 100 μl of methanol:acetic acid (3:1)
fixative was then added directly to each well. Cells were viewed
under a UV microscope with DAPI filter. Six replicate wells were
analyzed for each treatment by quantitative and qualitative
examination of four random fields in each well.</p>


<h5>Detection of apoptosis incidence by flow
cytometry</h5>
<p>Apoptosis incidence was detected by the Annexin
V-FITC apoptosis detection kit I (BD Pharmingen). Briefly, cells
that were attached to the plate as well as those present in the
super-natant were collected together and re-suspended in binding
buffer at a concentration of 1×10<span class="superscript">6</span> cells/ml. A 100 μl
sample of solution containing 1×10<span class="superscript">5</span> cells was incubated
with 5 μl of Annexin V-FITC and 5 μl of propidium iodide for 15 min
at room temperature in the dark, followed by addition of 400 μl of
binding buffer. Samples were analyzed by a fluorescence-activated
cell sorter (Beckman Coulter, Miami, FL, USA) within 1 h. Apoptotic
cells, including those staining positive for Annexin V-FITC and
negative for propidium iodide and those that were double positive,
were counted and reported as a percentage of the total cell
count.</p>


<h5>In vivo tumor xenograft studies</h5>
<p>The animal experiments and protocols were reviewed
and approved by the Institutional Animal Care and Use Committee of
the Shanghai Jiao Tong University School of Medicine. Six mice were
injected subcutaneously with 1×10<span class="superscript">8</span> MG-63 and HOS
osteosarcoma cells in 50 μl of PBS pre-mixed with an equal volume
of Matrigel matrix (Becton-Dickinson). Mice were monitored daily
and all mice developed a subcutaneous tumor. When the tumor size
reached approximately 5 mm in length, they were surgically removed,
cut into 1–2 mm<span class="superscript">3</span> pieces, and re-seeded individually into
other twelve mice. When tumor size reached approximately 5 mm in
length, the mice were randomly assigned to ad-BMP-9 and ad-GFP
groups, in which 15 μl of adenovirus was injected into the
subcutaneous tumors using a multi-site injection format. Injections
were repeated on the third day after initial treatment. The tumor
volume every three days was measured with a caliper, using the
formula volume = (length × width)<span class="superscript">2</span>/2.</p>


<h5>Statistical analysis</h5>
<p>The results obtained were expressed as the mean ± SE
from at least three independent experiments. One-way analysis of
variance (ANOVA) was used to analyze the differences between
groups. The LSD method of multiple comparisons was used when the
probability for ANOVA was statistically significant. Statistical
significance was set at P&lt;0.05.</p>



<h4>Results</h4>

<h5>The endogenous expression of BMP-9 in
osteosarcoma cell lines</h5>
<p>The endogenous expression of BMP-9 in human MG-63,
U-2 and HOS osteosarcoma cell lines was evaluated using RT-PCR and
western blot analysis. As shown in <a href="#f1-ijo-41-05-1809" class="linksColor">Fig. 1</a>, there were different levels of
mRNA and protein expression of BMP-9 in MG-63, U-2 and HOS
osteosarcoma cell lines, but the expression levels of BMP-9 were
significantly higher in U-2 cell line than in MG-63 and HOS cell
lines. Thus, we chose MG-63 and HOS osteosarcoma cell lines for
infection by the adBMP-9 adenovirus.</p><div id="f1-ijo-41-05-1809"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/41/5/IJO-41-05-1809-g00.jpg" title="Figure 1. - The endogenous expression of BMP-9 in&#xA;osteosarcoma cell lines. There were different levels of (A) mRNA&#xA;and (B) protein expression of BMP-9 in MG-63, U-2 and HOS cell&#xA;lines, but the expression levels of BMP-9 were significantly higher&#xA;in U-2 cell line than those in MG-63 and HOS cell lines, indicated&#xA;by real-time PCR and western blot assays."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/41/5/IJO-41-05-1809-g00.jpg"></img></td><td><h4>Figure 1.</h4><p class="bold">The endogenous expression of BMP-9 in
osteosarcoma cell lines. There were different levels of (A) mRNA
and (B) protein expression of BMP-9 in MG-63, U-2 and HOS cell
lines, but the expression levels of BMP-9 were significantly higher
in U-2 cell line than those in MG-63 and HOS cell lines, indicated
by real-time PCR and western blot assays.</p></td></tr></tbody></table></div></a></div>


<h5>The expression of BMP-9, PI3Kp85α and
p-AKT after infection with adBMP-9</h5>
<p>In order to enhance the exogenous expression of
BMP-9 in MG-63 and HOS osteosarcoma cells with relatively low
endogenous BMP-9 expression, constructed adenovirus vector adBMP-9
was used for infecting the MG-63 and HOS cell lines. In pilot
studies, the infection efficiency of adBMP-9 (MOI=100) in MG-63 and
HOS cell lines was greater than 80% under fluorescence microscopy
(<a href="#f2-ijo-41-05-1809" class="linksColor">Fig. 2B</a>). Real-time PCR and
western blot assays were performed at 48 h recovery to measure the
exogenous expression of BMP-9, PI3Kp85α and p-AKT. An obvious
increase of BMP-9 expression was observed in adBMP-9 group compared
with the ad-GFP group and CON group (<span class="superscript">**</span>P&lt;0.01), while
a marked decrease of PI3Kp85α and p-AKT expression was found in
adBMP-9 group compared with the ad-GFP group and CON group in MG-63
and HOS cell lines (<span class="superscript">**</span>P&lt;0.01) (<a href="#f2-ijo-41-05-1809" class="linksColor">Fig. 2A, C and D</a>), but no difference was
found between ad-GFP group and CON group in MG-63 and HOS cell
lines (P&gt;0.05). These data indicated that overexpression of
BMP-9 might block the PI3K/AKT signaling pathway in osteosarcoma
cells.</p><div id="f2-ijo-41-05-1809"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/41/5/IJO-41-05-1809-g01.jpg" title="Figure 2. - The expression of BMP-9, PI3Kp85α and&#xA;p-AKT after infection with adBMP-9 in MG-63 and HOS cell lines. (B)&#xA;Constructed adenovirus vector adBMP-9 was used for infecting the&#xA;MG-63 and HOS cell lines. The infection efficiency of adBMP-9&#xA;(MOI=100) in MG-63 and HOS cell lines was greater than 80% under&#xA;fluorescence microscopy. (A) Real-time PCR and (C and D) western&#xA;blot assays were performed at 48-h recovery to measure the&#xA;exogenous expression of BMP-9, PI3Kp85α and p-AKT, showing that an&#xA;obvious increase of BMP-9 expression was observed in adBMP-9 group&#xA;compared with the ad-GFP group and CON group&#xA;(**P&lt;0.01), while a marked decrease of PI3Kp85α and&#xA;p-AKT expression was found in adBMP-9 group compared with the&#xA;ad-GFP group and CON group in MG-63 and HOS cell lines&#xA;(**P&lt;0.01). No difference was found between ad-GFP&#xA;group and CON group in MG-63 and HOS cell lines (P&gt;0.05)."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/41/5/IJO-41-05-1809-g01.jpg"></img></td><td><h4>Figure 2.</h4><p class="bold">The expression of BMP-9, PI3Kp85α and
p-AKT after infection with adBMP-9 in MG-63 and HOS cell lines. (B)
Constructed adenovirus vector adBMP-9 was used for infecting the
MG-63 and HOS cell lines. The infection efficiency of adBMP-9
(MOI=100) in MG-63 and HOS cell lines was greater than 80% under
fluorescence microscopy. (A) Real-time PCR and (C and D) western
blot assays were performed at 48-h recovery to measure the
exogenous expression of BMP-9, PI3Kp85α and p-AKT, showing that an
obvious increase of BMP-9 expression was observed in adBMP-9 group
compared with the ad-GFP group and CON group
(**P&lt;0.01), while a marked decrease of PI3Kp85α and
p-AKT expression was found in adBMP-9 group compared with the
ad-GFP group and CON group in MG-63 and HOS cell lines
(**P&lt;0.01). No difference was found between ad-GFP
group and CON group in MG-63 and HOS cell lines (P&gt;0.05).</p></td></tr></tbody></table></div></a></div>


<h5>Inhibition of osteosarcoma cell
proliferation by adBMP-9</h5>
<p>Deregulated cell proliferation is a hallmark of
cancer (<a href="#b20-ijo-41-05-1809" class="linksColor">20</a>). In order to detect
the effect of adBMP-9 on osteosarcoma cell proliferation, we
investigated the proliferative activities of MG-63 and HOS cell
lines by MTT. As a result, it was indicated that adBMP-9
significantly reduced the proliferative activities of MG-63 and HOS
cell lines in a time-dependent manner compared with the ad-GFP
group and CON group. No difference was found between ad-GFP group
and CON group in MG-63 and HOS cell lines (<a href="#f3-ijo-41-05-1809" class="linksColor">Fig. 3A and B</a>). In addition, Ki-67 is at
the very heart of many essential cellular processes and determines
the tumor progression and the outcome of anticancer treatment. To
determine whether BMP-9 overexpression suppressed the endogenous
Ki-67 through translational repression, the expression of Ki-67 was
examined by western blot assay, indicating that the amount of Ki-67
expression was significantly decreased in adBMP-9 group compared
with the ad-GFP group and CON group in MG-63 and HOS cell lines
(<a href="#f3-ijo-41-05-1809" class="linksColor">Fig. 3C and D</a>). No difference was
found between ad-GFP group and CON group in MG-63 and HOS cell
lines. The results suggested that over-expression of BMP-9 might
inhibit osteosarcoma cell proliferation via downregulation of Ki-67
expression.</p><div id="f3-ijo-41-05-1809"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/41/5/IJO-41-05-1809-g02.jpg" title="Figure 3. - Inhibition of osteosarcoma cell&#xA;proliferation by adBMP-9 in MG-63 and HOS cell lines. (A and B) It&#xA;was indicated by MTT assay that adBMP-9 significantly reduced the&#xA;proliferative activities of MG-63 and HOS cell lines in a&#xA;time-dependent manner compared with the ad-GFP group and CON group.&#xA;No difference was found between ad-GFP group and CON group in MG-63&#xA;and HOS cell lines. (C and D) The expression of Ki-67 was examined&#xA;by western blot assay, indicating that the amount of Ki-67&#xA;expression was significantly decreased in adBMP-9 group compared&#xA;with the ad-GFP group and CON group in MG-63 and HOS cell lines. No&#xA;difference was found between ad-GFP group and CON group."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/41/5/IJO-41-05-1809-g02.jpg"></img></td><td><h4>Figure 3.</h4><p class="bold">Inhibition of osteosarcoma cell
proliferation by adBMP-9 in MG-63 and HOS cell lines. (A and B) It
was indicated by MTT assay that adBMP-9 significantly reduced the
proliferative activities of MG-63 and HOS cell lines in a
time-dependent manner compared with the ad-GFP group and CON group.
No difference was found between ad-GFP group and CON group in MG-63
and HOS cell lines. (C and D) The expression of Ki-67 was examined
by western blot assay, indicating that the amount of Ki-67
expression was significantly decreased in adBMP-9 group compared
with the ad-GFP group and CON group in MG-63 and HOS cell lines. No
difference was found between ad-GFP group and CON group.</p></td></tr></tbody></table></div></a></div>


<h5>Inhibition of osteosarcoma cell migration
by adBMP-9</h5>
<p>To determine the effect of adBMP-9 on MG-63 and HOS
cell migration, wound-healing assay was performed which showed that
the migration capacity of the osteosarcoma cells in adBMP-9 group
were markedly lower than those in ad-GFP group and CON group, but
no significant changes were found between ad-GFP group and CON
group (<a href="#f4-ijo-41-05-1809" class="linksColor">Fig. 4A</a>). Furthermore,
western blot assay was used to examine the effect of adBMP-9 on
MMP-9 expression. As shown in <a href="#f4-ijo-41-05-1809" class="linksColor">Fig. 4B
and C</a>, the expression of MMP-9 protein was significantly
inhibited in adBMP-9 group compared with the ad-GFP group and CON
group in MG-63 and HOS cell lines. No difference was found between
ad-GFP group and CON group. These data suggested that
overexpression of BMP-9 might inhibit cell migration via
down-regulation of MMP-9 expression.</p><div id="f4-ijo-41-05-1809"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/41/5/IJO-41-05-1809-g03.jpg" title="Figure 4. - Inhibition of osteosarcoma cell&#xA;migration by adBMP-9 in MG-63 and HOS cell lines. (A) Wound-healing&#xA;assay showed that the migration capacity of OS cells in adBMP-9&#xA;group was markedly lower than those in ad-GFP group and CON group.&#xA;No difference was found between ad-GFP group and CON group. (B and&#xA;C) Western blot assay was performed to examine the effect of&#xA;adBMP-9 on MMP-9 expression, showing that the expression of MMP-9&#xA;protein was significantly inhibited in adBMP-9 group compared with&#xA;the ad-GFP group and CON group in MG-63 and HOS cell lines. No&#xA;difference was found between ad-GFP group and CON group."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/41/5/IJO-41-05-1809-g03.jpg"></img></td><td><h4>Figure 4.</h4><p class="bold">Inhibition of osteosarcoma cell
migration by adBMP-9 in MG-63 and HOS cell lines. (A) Wound-healing
assay showed that the migration capacity of OS cells in adBMP-9
group was markedly lower than those in ad-GFP group and CON group.
No difference was found between ad-GFP group and CON group. (B and
C) Western blot assay was performed to examine the effect of
adBMP-9 on MMP-9 expression, showing that the expression of MMP-9
protein was significantly inhibited in adBMP-9 group compared with
the ad-GFP group and CON group in MG-63 and HOS cell lines. No
difference was found between ad-GFP group and CON group.</p></td></tr></tbody></table></div></a></div>


<h5>Induction of osteosarcoma cell apoptosis
by adBMP-9</h5>
<p>It has been shown that the action mechanism of many
anticancer factors is based on their ability to induce apoptosis.
Therefore, it was desirable that MG-63 and HOS osteosarcoma cells
treated with adBMP-9 underwent apoptosis as their mode of cell
death. At the end of the incubation period for 24, 48 and 72 h, the
osteosarcoma cells were stained with Hoechst 33342/PI double
staining and their cell nucleus was observed under the microscope
for apoptosis. As shown in <a href="#f5-ijo-41-05-1809" class="linksColor">Fig.
5A</a>, the number of MG-63 and HOS apoptotic cells (weak red and
strong blue staining) and necrotic cells (strong red and strong
blue staining) in adBMP-9 group significantly increased compared
with that in the ad-GFP group and CON group (weak red and weak blue
staining) in a time-dependent manner. As shown in <a href="#f5-ijo-41-05-1809" class="linksColor">Fig. 5B</a>, the apoptotic indexes of MG-63
and HOS cells in adBMP-9 group were also significantly higher than
those in ad-GFP group and CON group (<span class="superscript">*</span>P&lt;0.05,
<span class="superscript">**</span>P&lt;0.01). However, no difference was found between
ad-GFP group and CON group (P&gt;0.05). The apoptotic incidence was
also observed by flow cytometry at 24 h after the transfection
(<a href="#f6-ijo-41-05-1809" class="linksColor">Fig. 6A and B</a>) and the result
showed that the incidence of apoptotic cells significantly
increased in adBMP-9 group compared with that in the ad-GFP group
and CON group (<span class="superscript">**</span>P&lt;0.01), but no difference was found
between ad-GFP group and CON group (P&gt;0.05). These data
suggested that over-expression of BMP-9 could induce osteosarcoma
cell apoptosis.</p><div id="f5-ijo-41-05-1809"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/41/5/IJO-41-05-1809-g04.jpg" title="Figure 5. - Induction of osteosarcoma cell&#xA;apoptosis by adBMP-9 in MG-63 and HOS cell lines. (A) At the end of&#xA;the incubation period for 24, 48 and 72 h, the MG-63 and HOS cells&#xA;were stained with Hoechst 33342/PI double staining and their cell&#xA;nucleus was observed under microscopy for apoptosis, showing that&#xA;the number of MG-63 and HOS apoptotic cells (weak red and strong&#xA;blue staining) and necrotic cells (strong red and strong blue&#xA;staining) in adBMP-9 group significantly increased compared with&#xA;that in the ad-GFP group and CON group (weak red and week blue&#xA;staining) in a time dependent manner. (B) The apoptotic index of&#xA;MG-63 and HOS cells in adBMP-9 group was significantly higher than&#xA;that in ad-GFP group and CON group (*P&lt;0.05,&#xA;**P&lt;0.01), but no difference was found between ad-GFP&#xA;group and CON group (P&gt;0.05)."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/41/5/IJO-41-05-1809-g04.jpg"></img></td><td><h4>Figure 5.</h4><p class="bold">Induction of osteosarcoma cell
apoptosis by adBMP-9 in MG-63 and HOS cell lines. (A) At the end of
the incubation period for 24, 48 and 72 h, the MG-63 and HOS cells
were stained with Hoechst 33342/PI double staining and their cell
nucleus was observed under microscopy for apoptosis, showing that
the number of MG-63 and HOS apoptotic cells (weak red and strong
blue staining) and necrotic cells (strong red and strong blue
staining) in adBMP-9 group significantly increased compared with
that in the ad-GFP group and CON group (weak red and week blue
staining) in a time dependent manner. (B) The apoptotic index of
MG-63 and HOS cells in adBMP-9 group was significantly higher than
that in ad-GFP group and CON group (*P&lt;0.05,
**P&lt;0.01), but no difference was found between ad-GFP
group and CON group (P&gt;0.05).</p></td></tr></tbody></table></div></a></div><div id="f6-ijo-41-05-1809"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/41/5/IJO-41-05-1809-g05.jpg" title="Figure 6. - Evaluation of apoptotic incidence by&#xA;flow cytometry. (A) Representative graphs obtained by flow&#xA;cytometry analysis after double staining with Annexin V-FITC and&#xA;propidium iodide. Undamaged cells were stained with negative&#xA;Annexin V-FITC/PI (bottom left quadrant). (B) The apoptotic&#xA;incidence of MG-63 and HOS cells at the 24 h after transfection.&#xA;The frequency of apoptotic cells significantly increased in adBMP-9&#xA;group compared with that in the ad-GFP group and CON group&#xA;(**P&lt;0.01), but no difference was found between&#xA;ad-GFP group and CON group (P&gt;0.05)."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/41/5/IJO-41-05-1809-g05.jpg"></img></td><td><h4>Figure 6.</h4><p class="bold">Evaluation of apoptotic incidence by
flow cytometry. (A) Representative graphs obtained by flow
cytometry analysis after double staining with Annexin V-FITC and
propidium iodide. Undamaged cells were stained with negative
Annexin V-FITC/PI (bottom left quadrant). (B) The apoptotic
incidence of MG-63 and HOS cells at the 24 h after transfection.
The frequency of apoptotic cells significantly increased in adBMP-9
group compared with that in the ad-GFP group and CON group
(**P&lt;0.01), but no difference was found between
ad-GFP group and CON group (P&gt;0.05).</p></td></tr></tbody></table></div></a></div>


<h5>Antitumor effect of adBMP-9 in the
osteosarcoma xenograft model</h5>
<p>Our <span class="italic">in vitro</span> experiments confirmed that
adBMP-9 efficiently inhibited the growth and migration of MG-63 and
HOS cells. Whether BMP-9 has the same inhibitory effect on <span class="italic">in
vivo</span> osteosarcoma was not known. Therefore, we further
investigated the antitumor effect of adBMP-9 <span class="italic">in vivo</span> using
MG-63 and HOS xenograft models. The mean volumes of MG-63 and HOS
xenograft tumors were 70.21±15.30 mm<span class="superscript">3</span> and 75.45±18.29
mm<span class="superscript">3</span> in the experimental mice before treatment. At the
14th day, the average volumes of MG-63 and HOS xenograft tumors
were measured and found significantly smaller in adBMP-9 group than
those in the ad-GFP group (<a href="#f7-ijo-41-05-1809" class="linksColor">Fig. 7A and
B</a>). During the whole tumor growth period, the tumor growth
activity was measured. The tumors treated with adBMP-9 grew
substantially slower than the ad-GFP group (<a href="#f7-ijo-41-05-1809" class="linksColor">Fig. 7C and D</a>). When the tumors were
harvested, the average weights of MG-63 and HOS xenograft tumors in
adBMP-9 group were significantly lighter than those in the ad-GFP
group (<span class="superscript">**</span>P&lt;0.01) (<a href="#f7-ijo-41-05-1809" class="linksColor">Fig.
7E and F</a>). These results <span class="italic">in vivo</span> indicated that
overexpression of BMP-9 could inhibit MG-63 and HOS cell
growth.</p><div id="f7-ijo-41-05-1809"><a class="fancybox" data-fancybox-group="figures" href="/article_images/ijo/41/5/IJO-41-05-1809-g06.jpg" title="Figure 7. - Antitumor effect of adBMP-9 in the&#xA;osteosarcoma MG-63 and HOS xenograft models. (A and B) At the 14th&#xA;day, the average volumes of MG-63 and HOS xenograft tumors were&#xA;measured and found significantly smaller in adBMP-9 group than&#xA;those in the ad-GFP group. (C and D) During the whole tumor growth&#xA;period, the tumor growth activity was measured, showing that the&#xA;tumors treated with adBMP-9 grew substantially slower than the&#xA;ad-GFP group. (E and F) At the 14th day, the average weights of&#xA;MG-63 and HOS xenograft tumors were significantly lower in adBMP-9&#xA;group than those in the ad-GFP group (**P&lt;0.01)."><div class="panel"><table><tbody><tr><td width="115px"><img class="panel-image" src="/article_images/ijo/41/5/IJO-41-05-1809-g06.jpg"></img></td><td><h4>Figure 7.</h4><p class="bold">Antitumor effect of adBMP-9 in the
osteosarcoma MG-63 and HOS xenograft models. (A and B) At the 14th
day, the average volumes of MG-63 and HOS xenograft tumors were
measured and found significantly smaller in adBMP-9 group than
those in the ad-GFP group. (C and D) During the whole tumor growth
period, the tumor growth activity was measured, showing that the
tumors treated with adBMP-9 grew substantially slower than the
ad-GFP group. (E and F) At the 14th day, the average weights of
MG-63 and HOS xenograft tumors were significantly lower in adBMP-9
group than those in the ad-GFP group (**P&lt;0.01).</p></td></tr></tbody></table></div></a></div>



<h4>Discussion</h4>
<p>BMPs are multifunctional cytokines that regulate the
growth, differentiation and apoptosis of various cell types
(<a href="#b21-ijo-41-05-1809" class="linksColor">21</a>). BMP has also been proved to
be one of the significant factors in the prognosis of bone tumors
(<a href="#b22-ijo-41-05-1809" class="linksColor">22</a>), and detection of BMPs in
osteosarcoma has been reported in several studies (<a href="#b23-ijo-41-05-1809" class="linksColor">23</a>–<a href="#b25-ijo-41-05-1809" class="linksColor">25</a>).</p>
<p>The BMP-2/4, BMP-3, BMP-5, BMP-6, BMP-7 and BMP-8
were previously found highly expressed in osteosarcoma tissues
(<a href="#b6-ijo-41-05-1809" class="linksColor">6</a>), but BMP-9 expression in
osteosarcoma has not been reported. Our study documented for the
first time the endogenous expression of BMP-9 in MG-63, U-2 and HOS
osteosarcoma cells, and demonstrated that the expression level of
BMP-9 was significantly higher in U-2 cell line than that in MG-63
and HOS cell lines, which were chosen for infection by the adBMP-9
adenovirus. In pilot studies, the infectious efficiency of adBMP-9
in MG-63 and HOS cell lines was very high, and an obvious increase
of BMP-9 expression was observed in adBMP-9 group compared with the
ad-GFP group and CON group.</p>
<p>Studies have shown that BMP-9 is also produced by
hepatocytes and circulates mainly in an active mature form
complexed to its prodomain (<a href="#b26-ijo-41-05-1809" class="linksColor">26</a>),
and induces proliferation of multiple types of endothelial cells
<span class="italic">in vitro</span> and <span class="italic">in vivo</span> (<a href="#b27-ijo-41-05-1809" class="linksColor">27</a>). In contrast, we found in our study
that the overexpression of BMP-9 significantly reduced the
proliferative activities of MG-63 and HOS cell lines in a
time-dependent manner. More importantly, BMP-9 has been confirmed
to prevent the migration and invasiveness and induce apoptosis in
prostate cancer, which suggests that BMP-9 may be considered as a
tumor suppressor and apoptosis regulator in prostate cancer
(<a href="#b19-ijo-41-05-1809" class="linksColor">19</a>). Additionally, soluble
endoglin can specifically binds BMP-9 via its orphan domain,
inhibits blood vessel formation and suppresses tumor growth
(<a href="#b28-ijo-41-05-1809" class="linksColor">28</a>). By contrast, BMP-9 was also
reported to promote ovarian cancer cell proliferation through
ALK-2/Smad1/Smad4 pathway (<a href="#b29-ijo-41-05-1809" class="linksColor">29</a>).
We think that the response to BMP-9 is not accordant among all
cancers. The biological response of cancer cells to BMP-9 may
depend not only on the particular cell type or concentration of BMP
used, but also on the presence of other factors that are not yet
defined. Our gain-of-function studies <span class="italic">in vitro</span> and <span class="italic">in
vivo</span> using adBMP-9 revealed significant decrease in growth and
migration and increase in apoptosis in MG-63 and HOS cells,
suggesting that BMP-9 may function as a tumor suppressor in
osteosarcoma.</p>
<p>PI3K/AKT is a major pathway for malignant
progression in various tumors. It is involved in mediating survival
signals that rescue Ewing tumor from fibroblast growth factor
2-induced cell death (<a href="#b30-ijo-41-05-1809" class="linksColor">30</a>).
Blockade of Ras/PI3K/AKT pathways by statins reduces the expression
of TGF-β as angiogenic factors in mouse osteosarcoma (<a href="#b31-ijo-41-05-1809" class="linksColor">31</a>). While grifolin or celecoxib, a
cyclooxygease-2 inhibitor, induces apoptosis via inhibition of
PI3K/AKT signaling pathway in human osteosarcoma cells (<a href="#b32-ijo-41-05-1809" class="linksColor">32</a>,<a href="#b33-ijo-41-05-1809" class="linksColor">33</a>),
overexpression of BMI-1 promotes cell growth and resistance to
cisplatin treatment via activation of PI3K/AKT pathway in
osteosarcoma (<a href="#b34-ijo-41-05-1809" class="linksColor">34</a>). However, our
study indicated a marked decrease of PI3Kp85α and p-AKT expression
in adBMP-9 group compared with the ad-GFP group and CON group in
MG-63 and HOS cell lines, suggesting that overexpression of BMP-9
inhibited osteosarcoma cell growth and migration via blockade of
the PI3K/AKT signaling.</p>
<p>Ki-67 is a nuclear protein that is expressed in
proliferating cells and may be required for maintaining cell
proliferation, used as a marker for cell proliferation of
osteosarcoma (<a href="#b35-ijo-41-05-1809" class="linksColor">35</a>). MMP-9 is
thought to be key enzymes involved in the degradation of type IV
collagen and high level of MMP-9 in tissues is interralated with
tumor growth and invasion (<a href="#b36-ijo-41-05-1809" class="linksColor">36</a>,<a href="#b37-ijo-41-05-1809" class="linksColor">37</a>).
It is reported that PI3K/AKT pathway promotes the growth and
metastasis of malignant tumors via upregulation of Ki-67 and MMP-9
(<a href="#b38-ijo-41-05-1809" class="linksColor">38</a>). Our results showed a marked
decrease of Ki-67 and MMP-9 expression in adBMP-9 group compared
with the ad-GFP group and CON group in MG-63 and HOS cell lines,
suggesting that BMP-9 might downregulate the expression of Ki-67
and MMP-9 via blockade of the PI3K/AKT signaling pathway in
osteosarcoma cells.</p>
<p>To our knowledge, this is the first report
investigating the role of BMP-9 in the growth and migration of
osteosarcoma cells. Our investigation revealed that the enhanced
expression of BMP-9 in osteosarcoma cells by adBMP-9 exerted
inhibitory effects on growth and migration of osteosarcoma cells
possibly via blockade of the PI3K/AKT signaling. BMP-9 as a tumor
suppressor may provide a novel approach to human osteosarcoma
treatment.</p>



<a class="linksColor">
</a>
<a class="linksColor">
</a>
<h4>References</h4>
<table xmlns="http://www.w3.org/1999/xhtml" class="ref-list"><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">1.</span> <a name="b1-ijo-41-05-1809" id="b1-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e497" id="d7e497" shape="rect">
<!-- named anchor --></a>Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. <a target="xrefwindow" href="http://dx.doi.org/10.3322/caac.20107" id="d7e499" name="d7e499" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Global%20cancer%20statistics" id="d7e502" name="d7e502" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">2.</span> <a name="b2-ijo-41-05-1809" id="b2-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e507" id="d7e507" shape="rect">
<!-- named anchor --></a>Kim M and Choe S: BMPs and their clinical
potentials. BMB Rep. 44:619–634. 2011. <a target="xrefwindow" href="http://dx.doi.org/10.5483/BMBRep.2011.44.10.619" id="d7e509" name="d7e509" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=BMPs%20and%20their%20clinical%20potentials" id="d7e512" name="d7e512" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">3.</span> <a name="b3-ijo-41-05-1809" id="b3-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e517" id="d7e517" shape="rect">
<!-- named anchor --></a>Boon MR, van der Horst G, van der Pluijm
G, et al: Bone morphogenetic protein 7: a broad-spectrum growth
factor with multiple target therapeutic potency. Cytokine Growth
Factor Rev. 22:221–229. 2011. <a target="xrefwindow" href="http://dx.doi.org/10.1016/j.cytogfr.2011.08.001" id="d7e519" name="d7e519" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Bone%20morphogenetic%20protein%207:%20a%20broad-spectrum%20growth%20factor%20with%20multiple%20target%20therapeutic%20potency" id="d7e522" name="d7e522" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/21924665" id="d7e525" name="d7e525" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">4.</span> <a name="b4-ijo-41-05-1809" id="b4-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e530" id="d7e530" shape="rect">
<!-- named anchor --></a>Gobbi G, Sangiorgi L, Lenzi L, et al:
Seven BMPs and all their receptors are simultaneously expressed in
osteosarcoma cells. Int J Oncol. 20:143–147. 2002.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11743655" id="d7e532" name="d7e532" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">5.</span> <a name="b5-ijo-41-05-1809" id="b5-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e537" id="d7e537" shape="rect">
<!-- named anchor --></a>Yoshikawa H, Nakase T, Myoui A and Ueda T:
Bone morphogenetic proteins in bone tumors. J Orthop Sci.
9:334–340. 2004. <a target="xrefwindow" href="http://dx.doi.org/10.1007/s00776-004-0764-9" id="d7e539" name="d7e539" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Bone%20morphogenetic%20proteins%20in%20bone%20tumors" id="d7e542" name="d7e542" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">6.</span> <a name="b6-ijo-41-05-1809" id="b6-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e547" id="d7e547" shape="rect">
<!-- named anchor --></a>Sulzbacher I, Birner P, Trieb K,
Pichlbauer E and Lang S: The expression of bone morphogenetic
proteins in osteosarcoma and its relevance as a prognostic
parameter. J Clin Pathol. 55:381–385. 2002. <a target="xrefwindow" href="http://dx.doi.org/10.1136/jcp.55.5.381" id="d7e549" name="d7e549" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=The%20expression%20of%20bone%20morphogenetic%20proteins%20in%20osteosarcoma%20and%20its%20relevance%20as%20a%20prognostic%20parameter" id="d7e552" name="d7e552" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11986346" id="d7e555" name="d7e555" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">7.</span> <a name="b7-ijo-41-05-1809" id="b7-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e560" id="d7e560" shape="rect">
<!-- named anchor --></a>Sotobori T, Ueda T, Myoui A, et al: Bone
morphogenetic protein-2 promotes the haptotactic migration of
murine osteoblastic and osteosarcoma cells by enhancing
incorporation of integrin beta1 into lipid rafts. Exp Cell Res.
312:3927–3938. 2006. <a target="xrefwindow" href="http://dx.doi.org/10.1016/j.yexcr.2006.08.024" id="d7e562" name="d7e562" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Bone%20morphogenetic%20protein-2%20promotes%20the%20haptotactic%20migration%20of%20murine%20osteoblastic%20and%20osteosarcoma%20cells%20by%20enhancing%20incorporation%20of%20integrin%20beta1%20into%20lipid%20rafts" id="d7e565" name="d7e565" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">8.</span> <a name="b8-ijo-41-05-1809" id="b8-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e570" id="d7e570" shape="rect">
<!-- named anchor --></a>Weiss KR, Cooper GM, Jadlowiec JA, McGough
RL III and Huard J: VEGF and BMP expression in mouse osteosarcoma
cells. Clin Orthop Relat Res. 450:111–117. 2006. <a target="xrefwindow" href="http://dx.doi.org/10.1097/01.blo.0000229333.98781.56" id="d7e572" name="d7e572" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=VEGF%20and%20BMP%20expression%20in%20mouse%20osteosarcoma%20cells" id="d7e575" name="d7e575" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/16906080" id="d7e578" name="d7e578" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">9.</span> <a name="b9-ijo-41-05-1809" id="b9-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e583" id="d7e583" shape="rect">
<!-- named anchor --></a>Song JJ, Celeste AJ, Kong FM, Jirtle RL,
Rosen V and Thies RS: Bone morphogenetic protein-9 binds to liver
cells and stimulates proliferation. Endocrinology. 136:4293–4297.
1995.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/7664647" id="d7e585" name="d7e585" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">10.</span> <a name="b10-ijo-41-05-1809" id="b10-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e590" id="d7e590" shape="rect">
<!-- named anchor --></a>Ploemacher RE, Engels LJ, Mayer AE, Thies
S and Neben S: Bone morphogenetic protein 9 is a potent synergistic
factor for murine hemopoietic progenitor cell generation and colony
formation in serum-free cultures. Leukemia. 13:428–437. 1999.
<a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.leu.2401363" id="d7e592" name="d7e592" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Bone%20morphogenetic%20protein%209%20is%20a%20potent%20synergistic%20factor%20for%20murine%20hemopoietic%20progenitor%20cell%20generation%20and%20colony%20formation%20in%20serum-free%20cultures" id="d7e595" name="d7e595" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/10086734" id="d7e598" name="d7e598" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">11.</span> <a name="b11-ijo-41-05-1809" id="b11-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e604" id="d7e604" shape="rect">
<!-- named anchor --></a>Helm GA, Alden TD, Beres EJ, et al: Use of
bone morphogenetic protein-9 gene therapy to induce spinal
arthrodesis in the rodent. J Neurosurg. 92:191–196. 2000.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/10763690" id="d7e606" name="d7e606" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">12.</span> <a name="b12-ijo-41-05-1809" id="b12-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e611" id="d7e611" shape="rect">
<!-- named anchor --></a>López-Coviella I, Berse B, Krauss R, Thies
RS and Blusztajn JK: Induction and maintenance of the neuronal
cholinergic phenotype in the central nervous system by BMP-9.
Science. 289:313–316. 2000.</p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">13.</span> <a name="b13-ijo-41-05-1809" id="b13-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e616" id="d7e616" shape="rect">
<!-- named anchor --></a>Chen C, Grzegorzewski KJ, Barash S, et al:
An integrated functional genomics screening program reveals a role
for BMP-9 in glucose homeostasis. Nat Biotechnol. 21:294–301. 2003.
<a target="xrefwindow" href="http://dx.doi.org/10.1038/nbt795" id="d7e618" name="d7e618" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=An%20integrated%20functional%20genomics%20screening%20program%20reveals%20a%20role%20for%20BMP-9%20in%20glucose%20homeostasis" id="d7e621" name="d7e621" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/12598908" id="d7e624" name="d7e624" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">14.</span> <a name="b14-ijo-41-05-1809" id="b14-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e629" id="d7e629" shape="rect">
<!-- named anchor --></a>Truksa J, Peng H, Lee P and Beutler E:
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1
expression independently of Hfe, transferrin receptor 2 (Tfr2), and
IL-6. Proc Natl Acad Sci USA. 103:10289–10293. 2006. <a target="xrefwindow" href="http://dx.doi.org/10.1073/pnas.0603124103" id="d7e631" name="d7e631" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Bone%20morphogenetic%20proteins%202,%204,%20and%209%20stimulate%20murine%20hepcidin%201%20expression%20independently%20of%20Hfe,%20transferrin%20receptor%202%20(Tfr2),%20and%20IL-6" id="d7e634" name="d7e634" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/16801541" id="d7e637" name="d7e637" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">15.</span> <a name="b15-ijo-41-05-1809" id="b15-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e642" id="d7e642" shape="rect">
<!-- named anchor --></a>David L, Mallet C, Mazerbourg S, Feige JJ
and Bailly S: Identification of BMP9 and BMP10 as functional
activators of the orphan activin receptor-like kinase 1 (ALK1) in
endothelial cells. Blood. 109:1953–1961. 2007. <a target="xrefwindow" href="http://dx.doi.org/10.1182/blood-2006-07-034124" id="d7e644" name="d7e644" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Identification%20of%20BMP9%20and%20BMP10%20as%20functional%20activators%20of%20the%20orphan%20activin%20receptor-like%20kinase%201%20(ALK1)%20in%20endothelial%20cells" id="d7e647" name="d7e647" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17068149" id="d7e650" name="d7e650" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">16.</span> <a name="b16-ijo-41-05-1809" id="b16-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e655" id="d7e655" shape="rect">
<!-- named anchor --></a>Brown MA, Zhao Q, Baker KA, et al: Crystal
structure of BMP-9 and functional interactions with pro-region and
receptors. J Biol Chem. 280:25111–25118. 2005. <a target="xrefwindow" href="http://dx.doi.org/10.1074/jbc.M503328200" id="d7e657" name="d7e657" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Crystal%20structure%20of%20BMP-9%20and%20functional%20interactions%20with%20pro-region%20and%20receptors" id="d7e660" name="d7e660" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/15851468" id="d7e663" name="d7e663" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">17.</span> <a name="b17-ijo-41-05-1809" id="b17-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e668" id="d7e668" shape="rect">
<!-- named anchor --></a>Scharpfenecker M, van Dinther M, Liu Z, et
al: BMP-9 signals via ALK1 and inhibits hFGF-induced endothelial
cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci.
120:964–972. 2007. <a target="xrefwindow" href="http://dx.doi.org/10.1242/jcs.002949" id="d7e670" name="d7e670" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=BMP-9%20signals%20via%20ALK1%20and%20inhibits%20hFGF-induced%20endothelial%20cell%20proliferation%20and%20VEGF-stimulated%20angiogenesis" id="d7e673" name="d7e673" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17311849" id="d7e676" name="d7e676" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">18.</span> <a name="b18-ijo-41-05-1809" id="b18-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e681" id="d7e681" shape="rect">
<!-- named anchor --></a>Upton PD, Davies RJ, Trembath RC and
Morrell NW: Bone morphogenetic protein (BMP) and activin type II
receptors balance BMP9 signals mediated by activin receptor-like
kinase-1 in human pulmonary artery endothelial cells. J Biol Chem.
284:15794–15804. 2009. <a target="xrefwindow" href="http://dx.doi.org/10.1074/jbc.M109.002881" id="d7e683" name="d7e683" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Bone%20morphogenetic%20protein%20(BMP)%20and%20activin%20type%20II%20receptors%20balance%20BMP9%20signals%20mediated%20by%20activin%20receptor-like%20kinase-1%20in%20human%20pulmonary%20artery%20endothelial%20cells" id="d7e686" name="d7e686" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">19.</span> <a name="b19-ijo-41-05-1809" id="b19-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e691" id="d7e691" shape="rect">
<!-- named anchor --></a>Ye L, Kynaston H and Jiang WG: Bone
morphogenetic protein-9 induces apoptosis in prostate cancer cells,
the role of prostate apoptosis response-4. Mol Cancer Res.
6:1594–1606. 2008. <a target="xrefwindow" href="http://dx.doi.org/10.1158/1541-7786.MCR-08-0171" id="d7e693" name="d7e693" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Bone%20morphogenetic%20protein-9%20induces%20apoptosis%20in%20prostate%20cancer%20cells,%20the%20role%20of%20prostate%20apoptosis%20response-4" id="d7e696" name="d7e696" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/18922975" id="d7e699" name="d7e699" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">20.</span> <a name="b20-ijo-41-05-1809" id="b20-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e704" id="d7e704" shape="rect">
<!-- named anchor --></a>Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. <a target="xrefwindow" href="http://dx.doi.org/10.1016/j.cell.2011.02.013" id="d7e706" name="d7e706" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Hallmarks%20of%20cancer:%20the%20next%20generation" id="d7e709" name="d7e709" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/21376230" id="d7e712" name="d7e712" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">21.</span> <a name="b21-ijo-41-05-1809" id="b21-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e717" id="d7e717" shape="rect">
<!-- named anchor --></a>Yang LJ and Jin Y: Immunohistochemical
observation of bone morphogenetic protein in normal and abnormal
conditions. Clin Orthop Relat Res. 257:249–256. 1990.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/2379362" id="d7e719" name="d7e719" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">22.</span> <a name="b22-ijo-41-05-1809" id="b22-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e725" id="d7e725" shape="rect">
<!-- named anchor --></a>Laiitnen M, Jortikka L, Halttunen T, et
al: Measurement of total and local bone morphogenetic protein
concentration in bone tumours. Int Orthop. 21:188–193. 1997.
<a target="xrefwindow" href="http://dx.doi.org/10.1007/s002640050148" id="d7e727" name="d7e727" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Measurement%20of%20total%20and%20local%20bone%20morphogenetic%20protein%20concentration%20in%20bone%20tumours" id="d7e730" name="d7e730" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/9266301" id="d7e733" name="d7e733" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">23.</span> <a name="b23-ijo-41-05-1809" id="b23-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e738" id="d7e738" shape="rect">
<!-- named anchor --></a>Yoshikawa H, Shimizu K, Nakase T and
Takaoka K: Periosteal sunburst speculation in osteosarcoma. A
possible role for bone morphogenetic protein. Clin Orthop Relat
Res. 308:213–219. 1994.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/7955686" id="d7e740" name="d7e740" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">24.</span> <a name="b24-ijo-41-05-1809" id="b24-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e745" id="d7e745" shape="rect">
<!-- named anchor --></a>Yoshikawa H, Retting WJ, Lane JM, et al:
Immunohistochemical detection of bone morphogenetic protein in bone
and soft-tissue sarcomas. Cancer. 74:842–847. 1994. <a target="xrefwindow" href="http://dx.doi.org/10.1002/1097-0142(19940801)74:3%3C842::AID-CNCR2820740309%3E3.0.CO;2-B" id="d7e747" name="d7e747" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Immunohistochemical%20detection%20of%20bone%20morphogenetic%20protein%20in%20bone%20and%20soft-tissue%20sarcomas" id="d7e750" name="d7e750" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/8039112" id="d7e753" name="d7e753" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">25.</span> <a name="b25-ijo-41-05-1809" id="b25-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e758" id="d7e758" shape="rect">
<!-- named anchor --></a>Yoshikawa H, Retting WJ, Takaoka K, et al:
Expression of bone morphogenetic proteins in human osteosarcoma.
Immunohistochemical detection with monoclonal antibody. Cancer.
73:85–91. 1994. <a target="xrefwindow" href="http://dx.doi.org/10.1002/1097-0142(19940101)73:1%3C85::AID-CNCR2820730116%3E3.0.CO;2-8" id="d7e760" name="d7e760" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Expression%20of%20bone%20morphogenetic%20proteins%20in%20human%20osteosarcoma.%20Immunohistochemical%20detection%20with%20monoclonal%20antibody" id="d7e763" name="d7e763" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">26.</span> <a name="b26-ijo-41-05-1809" id="b26-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e768" id="d7e768" shape="rect">
<!-- named anchor --></a>Bidart M, Ricard N, Levet S, et al: BMP9
is produced by hepatocytes and circulates mainly in an active
mature form complexed to its prodomain. Cell Mol Life Sci.
69:313–324. 2012. <a target="xrefwindow" href="http://dx.doi.org/10.1007/s00018-011-0751-1" id="d7e770" name="d7e770" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=BMP9%20is%20produced%20by%20hepatocytes%20and%20circulates%20mainly%20in%20an%20active%20mature%20form%20complexed%20to%20its%20prodomain" id="d7e773" name="d7e773" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/21710321" id="d7e776" name="d7e776" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">27.</span> <a name="b27-ijo-41-05-1809" id="b27-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e781" id="d7e781" shape="rect">
<!-- named anchor --></a>Suzuki Y, Ohga N, Morishita Y, et al:
BMP-9 induces proliferation of multiple types of endothelial cells
in vitro and in vivo. J Cell Sci. 123:1684–1692. 2010. <a target="xrefwindow" href="http://dx.doi.org/10.1242/jcs.061556" id="d7e783" name="d7e783" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=BMP-9%20induces%20proliferation%20of%20multiple%20types%20of%20endothelial%20cells%20in%20vitro%20and%20in%20vivo" id="d7e786" name="d7e786" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/20406889" id="d7e789" name="d7e789" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">28.</span> <a name="b28-ijo-41-05-1809" id="b28-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e794" id="d7e794" shape="rect">
<!-- named anchor --></a>Castonguay R, Werner ED, Matthews RG, et
al: Soluble endoglin specifically binds bone morphogenetic proteins
9 and 10 via its orphan domain, inhibits blood vessel formation,
and suppresses tumor growth. J Biol Chem. 286:30034–30046. 2011.
<a target="xrefwindow" href="http://dx.doi.org/10.1074/jbc.M111.260133" id="d7e796" name="d7e796" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Soluble%20endoglin%20specifically%20binds%20bone%20morphogenetic%20proteins%209%20and%2010%20via%20its%20orphan%20domain,%20inhibits%20blood%20vessel%20formation,%20and%20suppresses%20tumor%20growth" id="d7e799" name="d7e799" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">29.</span> <a name="b29-ijo-41-05-1809" id="b29-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e804" id="d7e804" shape="rect">
<!-- named anchor --></a>Herrera B, van Dinther M, Ten Dijke P and
Inman GJ: Autocrine bone morphogenetic protein-9 signals through
activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian
cancer cell proliferation. Cancer Res. 69:9254–9262. 2009.
<a target="xrefwindow" href="http://dx.doi.org/10.1158/0008-5472.CAN-09-2912" id="d7e806" name="d7e806" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Autocrine%20bone%20morphogenetic%20protein-9%20signals%20through%20activin%20receptor-like%20kinase-2/Smad1/Smad4%20to%20promote%20ovarian%20cancer%20cell%20proliferation" id="d7e809" name="d7e809" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/19996292" id="d7e812" name="d7e812" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">30.</span> <a name="b30-ijo-41-05-1809" id="b30-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e817" id="d7e817" shape="rect">
<!-- named anchor --></a>Hotfilder M, Sondermann P, Senss A, et al:
PI3K/AKT is involved in mediating survival signals that rescue
Ewing tumor cells from fibroblast growth factor 2-induced cell
death. Br J Cancer. 92:705–710. 2005. <a target="xrefwindow" href="http://dx.doi.org/10.1038/sj.bjc.6602384" id="d7e819" name="d7e819" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=PI3K/AKT%20is%20involved%20in%20mediating%20survival%20signals%20that%20rescue%20Ewing%20tumor%20cells%20from%20fibroblast%20growth%20factor%202-induced%20cell%20death" id="d7e822" name="d7e822" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/15685229" id="d7e825" name="d7e825" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">31.</span> <a name="b31-ijo-41-05-1809" id="b31-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e830" id="d7e830" shape="rect">
<!-- named anchor --></a>Tsubaki M, Yamazoe Y, Yanae M, et al:
Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins
reduces the expression of bFGF, HGF, and TGF-β as angiogenic
factors in mouse osteosarcoma. Cytokine. 54:100–107.
2011.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/21292498" id="d7e832" name="d7e832" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">32.</span> <a name="b32-ijo-41-05-1809" id="b32-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e837" id="d7e837" shape="rect">
<!-- named anchor --></a>Jin S, Pang RP, Shen JN, et al: Grifolin
induces apoptosis via inhibition of PI3K/AKT signaling pathway in
human osteosarcoma cells. Apoptosis. 12:1317–1326. 2007. <a target="xrefwindow" href="http://dx.doi.org/10.1007/s10495-007-0062-z" id="d7e839" name="d7e839" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Grifolin%20induces%20apoptosis%20via%20inhibition%20of%20PI3K/AKT%20signaling%20pathway%20in%20human%20osteosarcoma%20cells" id="d7e842" name="d7e842" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/17333316" id="d7e845" name="d7e845" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">33.</span> <a name="b33-ijo-41-05-1809" id="b33-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e851" id="d7e851" shape="rect">
<!-- named anchor --></a>Liu B, Shi ZL, Feng J and Tao HM:
Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human
osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt. Cell
Biol Int. 32:494–501. 2008. <a target="xrefwindow" href="http://dx.doi.org/10.1016/j.cellbi.2007.10.008" id="d7e853" name="d7e853" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Celecoxib,%20a%20cyclooxygenase-2%20inhibitor,%20induces%20apoptosis%20in%20human%20osteosarcoma%20cell%20line%20MG-63%20via%20down-regulation%20of%20PI3K/Akt" id="d7e856" name="d7e856" shape="rect">Google Scholar</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">34.</span> <a name="b34-ijo-41-05-1809" id="b34-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e861" id="d7e861" shape="rect">
<!-- named anchor --></a>Wu Z, Min L, Chen D, et al: Overexpression
of BMI-1 promotes cell growth and resistance to cisplatin treatment
in osteosarcoma. PLoS One. 6:e146482011. <a target="xrefwindow" href="http://dx.doi.org/10.1371/journal.pone.0014648" id="d7e863" name="d7e863" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Overexpression%20of%20BMI-1%20promotes%20cell%20growth%20and%20resistance%20to%20cisplatin%20treatment%20in%20osteosarcoma" id="d7e866" name="d7e866" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/21311599" id="d7e869" name="d7e869" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">35.</span> <a name="b35-ijo-41-05-1809" id="b35-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e874" id="d7e874" shape="rect">
<!-- named anchor --></a>Hernández-Rodríguez NA, Correa E, Sotelo
R, et al: Ki-67: a proliferative marker that may predict pulmonary
metastases and mortality of primary osteosarcoma. Cancer Detect
Prev. 25:210–215. 2001.<a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/11341357" id="d7e876" name="d7e876" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">36.</span> <a name="b36-ijo-41-05-1809" id="b36-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e881" id="d7e881" shape="rect">
<!-- named anchor --></a>Loukopoulos P, O’Brien T, Ghoddusi M,
Mungall BA and Robinson WF: Characterization of three novel canine
osteosarcoma cell lines producing high levels of matrix
metal-loproteinases. Res Vet Sci. 77:131–141. 2004. <a target="xrefwindow" href="http://dx.doi.org/10.1016/j.rvsc.2004.01.006" id="d7e883" name="d7e883" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Characterization%20of%20three%20novel%20canine%20osteosarcoma%20cell%20lines%20producing%20high%20levels%20of%20matrix%20metal-loproteinases" id="d7e886" name="d7e886" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/15196903" id="d7e889" name="d7e889" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">37.</span> <a name="b37-ijo-41-05-1809" id="b37-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e894" id="d7e894" shape="rect">
<!-- named anchor --></a>Cawston TE and Wilson AJ: Understanding
the role of tissue degrading enzymes and their inhibitors in
development and disease. Best Pract Res Clin Rheumatol.
20:983–1002. 2006. <a target="xrefwindow" href="http://dx.doi.org/10.1016/j.berh.2006.06.007" id="d7e896" name="d7e896" shape="rect">View Article</a> : <a target="xrefwindow" href="http://scholar.google.com/scholar_lookup?title=Understanding%20the%20role%20of%20tissue%20degrading%20enzymes%20and%20their%20inhibitors%20in%20development%20and%20disease" id="d7e899" name="d7e899" shape="rect">Google Scholar</a> : <a target="xrefwindow" href="http://www.ncbi.nlm.nih.gov/pubmed/16980219" id="d7e902" name="d7e902" shape="rect">PubMed/NCBI</a></p>
</td></tr><tr><td class="ref-label" rowspan="1" colspan="1">
<p class="ref-label"><span class="label">38.</span> <a name="b38-ijo-41-05-1809" id="b38-ijo-41-05-1809" shape="rect">
<!-- named anchor --></a></p>
</td><td class="ref-content" rowspan="1" colspan="1">
<p class="citation"><a name="d7e907" id="d7e907" shape="rect">
<!-- named anchor --></a>Fu Y, Zhang Q, Kang C, et al: Inhibitory
effects of adenovirus mediated COX-2, Akt1 and PIK3R1 shRNA on the
growth of malignant tumor cells <i>in vitro</i> and <i>in vivo</i>.
Int J Oncol. 35:583–591. 2009.</p>
</td></tr></table>





</div>
						</div>

						<div>
						   
						</div>

						<div>
							
						</div>

						<div id="moreLikeThisDiv">
	
	<h4>Related Articles</h4>
	<ul style="list-style-type:disc" id="moreLikeThisUl" class="moreLikeThisClassFragment">
        
     </ul>
	          		
		
	</div>

						<div class="article_interactive">
							<ul class="article_icons">
								<li><a href="/10.3892/ijo.2012.1617/abstract"><img
										src="/resources/images/iconabstract.png" alt="Abstract" /></a></li>

								<li><a href="/10.3892/ijo.2012.1617?text=fulltext">
										<img src="/resources/images/iconarticle.png"
										title="View Full Article" />
								</a> </li>

								<li><a href="/10.3892/ijo.2012.1617/download"> <img
										src="/resources/images/icondownload.png"
										title="Download Article" />
								</a> </li>

							</ul>

							<!-- AddThis Button -->
							<ul
								class="article_sharing addthis_toolbox addthis_default_style addthis_32x32_style">

								

								

								

								<li><a
									class="at300b"
									href="https://twitter.com/intent/follow?screen_name=@IjOncology">
										<img src="/resources/images/twitter_32.png"
										alt="Twitter" />
								</a></li>

								

								

								

								
								<li><a class="addthis_button_facebook"></a></li>
								<li><a class="addthis_button_preferred_3"></a></li>
								<li><a class="addthis_button_preferred_4"></a></li>
								<li><a class="addthis_button_compact"></a></li>
							</ul>
						</div>
					</div>
				</div>

				<div class="journal_information">
					<!-- Duplicated from Journal to avoid caching issue if a fragment -->
					<div class="journal_details">
						<div>
							<img src="/ISSUE_IMAGES/ijo_41_5.jpg"
								alt="Journal Cover" />
						</div>
						
											
						
						<p class="bold">
							<span class="bold">November 2012</span> 
							<br/>
							<span>Volume 41 Issue 5</span>
						</p>
						<p>
							Print ISSN: <span>1019-6439</span><br />
							Online ISSN:<span>1791-2423</span><br />
						</p>

						<p>
							<a href="/myaccount/updateaccountdetails?etocUpdate=1">Sign
								up for eToc alerts</a>
						</p>

						<p>
							<a href="/var/library_recommendation_form.pdf">Recommend to
								Library</a>
						</p>
					</div>

					<div class="article_sidebar">
						<ul>
							<li class="sidebar_title">Article Options</li>
							<li class="sidebar_subtitle">Viewing Options</li>
							<li><a href="/10.3892/ijo.2012.1617/abstract">View
									Abstract</a></li>
							<li><a id="isFullTextVisible" href="/10.3892/ijo.2012.1617?text=fulltext">Full
									Text</a></li>
							<li><a id="downloadPDFURL" href="/10.3892/ijo.2012.1617/download">
									Download PDF </a> </li>


							<li>
								</li>

							<li class="sidebar_subtitle">Citations</li>
							<li><a href='#' class='osx'>Cite This Article</a></li>
							<li><a href="/downloadRisFile/10.3892/ijo.2012.1617">Download Citation</a></li>



							<li id="track_citation"><a href="/trackCitation/10.3892/ijo.2012.1617"
								title="If you would like to be notified via email each time this article is cited, please click on the link.">Create
									Citation Alert</a></li>
							<li id="remove_track_citation"><a href="/removeTrackCitation/10.3892/ijo.2012.1617"
								title="If you would like not to be notified via email each time this article is cited, please click on the link.">Remove
									Citation Alert</a></li>
							<li><a href="http://scholar.google.co.uk/scholar?hl=en&amp;q=related:http://www.spandidos-publications.com/10.3892/ijo.2012.1617">Cited
									By</a></li>
							<li class="sidebar_subtitle">Related Articles</li>
							<li><a href="#moreLikeThisDiv">on Spandidos Publications</a></li>
							<li class="sidebar_subtitle">Similar Articles</li>
							<li><a href="http://scholar.google.co.uk/scholar?hl=en&amp;q=related:http://www.spandidos-publications.com/10.3892/ijo.2012.1617">on
									Google Scholar</a></li>
							<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?cmd=Link&amp;db=pubmed&amp;dbFrom=PubMed&amp;from_uid=23420&amp;holding=f1000,f1000m,isrctn">on
									Pub Med</a></li>
							<li class="sidebar_subtitle">Copyright</li>
							<li><a href="http://www.copyright.com/openurl.do?issn=1791-2423">&copy;
									Get Permissions</a></li>
						</ul>

						<ul class="fixed_width_scopus">

							<li class="sidebar_title"><a href="/ijo">Journal Metrics</a></li>
							<li>Impact
								Factor: <span class="impact_factor_font">5.65</span>
							</li>

							<li>Ranked
								<span class="impact_factor_font"></span>

								<span>Oncology</span> <br /> (total
								number of cites)
							</li>

							<li>
								CiteScore: <span class="impact_factor_font">8.2</span> 
							</li>

							<li>CiteScore
								Rank: <span class="impact_factor_font">Q1: #52/340</span> <span>Oncology</span> 
							</li>

							<li>
								Source Normalized Impact per Paper (SNIP): <span
								class="impact_factor_font">1.045</span>
								
							</li>
							<li>
								SCImago Journal Rank (SJR): <span class="impact_factor_font">1.405</span> 
							</li>
						</ul>
					</div>






					<div class="article_sidebar twitter-articles">
						<div>
							<a class="twitter-timeline" data-width="25" data-tweet-limit="5"
								href="https://twitter.com/IjOncology?ref_src=twsrc%5Etfw">Tweets
								by @IjOncology</a>
						</div>
						<div class="article-twitter-buttons">
							<a href="https://twitter.com/IjOncology?ref_src=twsrc%5Etfw"
								class="twitter-follow-button" data-show-screen-name="false"
								data-dnt="true" data-show-count="false">Follow @IjOncology</a>

						</div>
					</div>


					

					


					


					

					

					


					

				</div>


			</div>

		</div>





		<div class="wide">
	
	<div class="event fixed_width">
			<a id="downloadCancerStoryPdf"  class="staticContent" href="#">
					<img src="/resources/images/cancer_story_banner.jpg" alt="The Cancer Story" />
			</a>
				
				
		</div>
	
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/rome2020.html" class="staticContent">
				<img src="/resources/images/1st_conference.jpg" alt="International Symposium on Molecular Medicine Conference Banner" />
				</a>				
		</div>
		
				
		<div class="event fixed_width">
				<a href="/pages/conference" class="staticContent">
				<img src="/resources/images/conferencebanner.jpg" alt="World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner" />
				</a>					
		</div>
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/china2020.html" class="staticContent">
				<img src="/resources/images/3rd_conference.jpg" alt="28th International Symposium on Molecular Medicine" />
				</a>				
		</div>
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com/chile2020.html" class="staticContent">
				<img src="/resources/images/2nd_conference.jpg" alt="International Symposium on Molecular Medicine Conference Banner" />
				</a>				
		</div>	
		
		
		<div class="event fixed_width">
				<a href="http://www.worldacademyofsciences.com" class="staticContent">
				<img src="/resources/images/world_of_academy_banner.jpg" alt="World Academy Of Sciences Banner" />
				</a>				
		</div>
	
			
			
		
		
	</div>
		<div class="footer wide">
	    
		 <div id="navbar" align="center" class="fixed_width footer">
			 			 
		 <div class="gdpr_table" >
			<div class="gdpr_row">
				<div class="gdpr_cell_header">
					<p><strong>This site uses cookies</strong></p>
				</div>		
					
			</div>
			<div class="gdpr_row">
				<div class="gdpr_cell_text">
					<p>You can change your cookie settings at any time by following the instructions in our <a	href="https://www.spandidos-publications.com/pages/cookies"	target="_blank">Cookie Policy</a>. To find out more, you may read our
					<a	href="https://www.spandidos-publications.com/pages/privacy"	target="_blank">Privacy Policy</a>. 
					<a href="#"  id="gdprButton"	class="gdpr_button">I agree</a>	
					</p>
				</div>			
						
			</div>
		</div>
			  
		</div>


		<div class="footer fixed_width">
				<div class="footer_copyright">
						<p  id="rightsReserved">0 </p>
			</div>
			
			
			<div class="footer_links">
				<ul class="social">
					<li>
						<a href="https://twitter.com/intent/follow?screen_name=@SpandidosP">  <img src="/resources/images/twitter.png" alt="Twitter"/> </a>             
					</li>
					<li>
						<a href="http://www.linkedin.com/company/2926613" title="Follow us on LinkedIn"><img src="/resources/images/linkedin.png" alt="LinkedIn"/></a>
					</li>
					<li>
						<a href="https://www.facebook.com/SpandidosPublications" title="Likes us on Facebook"><img src="/resources/images/facebook.png" alt="Facebook"/></a>
					</li>
					
				</ul>
				<ul class="footer_nav">
					<li><a href="/pages/about" id="about" class="staticContent">About</a></li>
					<li>
						<a href="/pages/contact" id="Contact" class="staticContent">Contact</a>
					</li>
					<li><a href="/pages/help">Help</a></li>
					<li><a href="/pages/cookies">Cookie Policy</a></li>
					<li><a href="/pages/privacy">Privacy Policy</a></li>

				</ul>
			</div>
		</div>
		
		 
		<div id="growl" class="bottom-left"></div>
		
	<!--Add the following script at the bottom of the web page (before </body></html>)-->
<script type="text/javascript">function add_chatwidget(){var hccid=66058258;var nt=document.createElement("script");nt.async=true;nt.src="https://www.mylivechat.com/chatwidget.aspx?hccid="+hccid;var ct=document.getElementsByTagName("script")[0];ct.parentNode.insertBefore(nt,ct);}
add_chatwidget();</script>
		
		<script src="/resources/js/jquery-3.4.1.min.js" type="text/javascript"></script>
		<script src="/resources/js/jquery-migrate-3.1.0.min.js" type="text/javascript"></script>

		<script src="/resources/js/app.js" type="text/javascript"></script>
		<script src="/resources/js/js.cookie-2.2.0.min.js"></script>
		
		 <script>
  		  	/*<![CDATA[*/
  		  	  $(document).ready(function () {
  		  		  		  		
  		  		if(null){  		  			
  		  		
  		  			sessionStorage.setItem("orcid_logout_uri", null);
  		  		}
  	
  		  		$("#rightsReserved").html('Copyright &copy; Spandidos Publications ' +(new Date()).getFullYear()+'. All rights reserved.');
  		  	});
  		  		
			 /*]]>*/
   		 </script>
		
		<script type="text/javascript">
			(function(b, o, i, l, e, r) {
				b.GoogleAnalyticsObject = l;
				b[l] || (b[l] =
						function() {
							(b[l].q = b[l].q || []).push(arguments)
						});
				b[l].l = +new Date;
				e = o.createElement(i);
				r = o.getElementsByTagName(i)[0];
				e.src = '//www.google-analytics.com/analytics.js';
				r.parentNode.insertBefore(e, r)
			}(window, document, 'script', 'ga'));
			ga('create', 'UA-45385578-1');
			ga('send', 'pageview');
		</script>
			<script async="async" crossorigin="anonymous" src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
		<!-- Google Code for English -->
		<!-- Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories. For instructions on adding this tag and more information on the above requirements, read the setup guide: google.com/ads/remarketingsetup -->
		<script type="text/javascript">
			/* <![CDATA[ */
			var google_conversion_id = 982681053;
			var google_conversion_label = "ewoHCKvwggoQ3YvK1AM";
			var google_custom_params = window.google_tag_params;
			var google_remarketing_only = true;
			/* ]]> */
		</script>
		<script type="text/javascript" src="//www.googleadservices.com/pagead/conversion.js">
		</script>
		
		<noscript>
			<div style="display:inline;">
				<img height="1" width="1" style="border-style:none;" alt="" src="//googleads.g.doubleclick.net/pagead/viewthroughconversion/982681053/?value=1.00&amp;label=ewoHCKvwggoQ3YvK1AM&amp;guid=ON&amp;script=0"/>
			</div>
		</noscript>
	<script>
    /*<![CDATA[*/
    	
    	$( "#gdprButton" ).click(function() {
    		Cookies.set('spandidos-gdpr', 'true', { expires: 365 });
   		 	$('#navbar').hide();
   		   $(window).scroll(function() {      		
         	 $('#navbar').hide();      		  
         	});
		});
		
		$('#logout').click(function() { 					
					
			forceSignOut();					
		});
    	
    	function forceSignOut(){
    		
    		let ocridlogouturl = sessionStorage.getItem("orcid_logout_uri");    		
    		ocridlogouturl = removeDoubleQuote(ocridlogouturl);    		
    		
    		$.ajax({
                url: ocridlogouturl,
                dataType: 'jsonp',
                success: function(result,status,xhr) {
                    console.log("Logged In: " + result.loggedIn);
                },
                error: function (xhr, status, error) {
                	console.log(status);
                }
            });
    	}
    	
    	function removeDoubleQuote(url){
    		return url.replace(/['"]+/g, '');
    	}
    
    	//Show guest editors list only if it has a person
        $(document).ready(function () {	
        	
	  		$( ".guestEditors" ).each(function() {
	  			
	  			if($(this).children().length > 0) {
		  			$(this).parent().show();
		  		}
	  		 
	  		});
	  	});
	/*]]>*/
	 </script>
		
	</div>

		<script type='text/javascript'
			src="/resources/js/jquery.simplemodal.js"></script>
		<script type='text/javascript' src="/resources/js/osx.js"></script>
		<!-- modal content -->
		<div id="osx-modal-content">
			<div id="osx-modal-title">Copy and paste a formatted citation</div>
			<div class="close">
				<a href="#" class="simplemodal-close">x</a>
			</div>
			<div id="osx-modal-data">
				<div class="inline">
					<div>
						<div class="citationFormat">Spandidos Publications style</div>
						<div class="citation">Li B, Yang Y, Jiang S, Ni B, Chen K and Jiang L: Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714. Int J Oncol 41: 1809-1819, 2012</div>
					</div>
					<div>
						<div class="citationFormat">APA</div>
						<div class="citation">Li, B., Yang, Y., Jiang, S., Ni, B., Chen, K., &amp; Jiang, L. (2012). Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714. International Journal of Oncology, 41, 1809-1819. https://doi.org/10.3892/ijo.2012.1617</div>
					</div>
					<div>
						<div class="citationFormat">MLA</div>
						<div class="citation">Li, B.,  Yang, Y.,  Jiang, S.,  Ni, B.,  Chen, K.,  Jiang, L.&quot;Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714&quot;. International Journal of Oncology 41.5 (2012): 1809-1819.</div>
					</div>
					<div>
						<div class="citationFormat">Chicago</div>
						<div class="citation">Li, B.,  Yang, Y.,  Jiang, S.,  Ni, B.,  Chen, K.,  Jiang, L.&quot;Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway Corrigendum in /10.3892/ijo.2016.3714&quot;. International Journal of Oncology 41, no. 5 (2012): 1809-1819. https://doi.org/10.3892/ijo.2012.1617</div>
					</div>
				</div>
			</div>
		</div>

		<!-- Used to generate counter -->
		<input type="hidden" id="doid" value="10.3892/ijo.2012.1617" />
		<input type="hidden" id="toa"
			value="F" /> <input
			type="hidden" id="ptvstatus" value="F12" />
		<input type="hidden" id="user_id"
			value="" />
		<input type="hidden" id="journal_id" value="ijo" /> <input
			type="hidden" id="alert_track_citation_message"
			value="" />

		<script src="/resources/js/counter.js"></script>
		<script type='text/javascript'
			src='https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js'></script>
		<script type="text/javascript">var addthis_config = addthis_config||{}; addthis_config.data_track_addressbar = false;</script>
		<script type="text/javascript"
			src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=ra-4fe476482ba42f68"></script>

		<script async="async" crossorigin="anonymous"
			src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
		<script src="https://code.jquery.com/ui/1.11.1/jquery-ui.min.js"></script>
		<script src="https://cdn.tiny.cloud/1/560gz528beukra3kb9syq7iido8yu0in5iysfds42lt1q48q/tinymce/4.5.7-72/tinymce.min.js" type="text/javascript"></script> 


		<!-- Add fancyBox main JS and CSS files -->
		<script type="text/javascript"
			src="/resources/js/jquery.fancybox.js"></script>
		<script src="/resources/js/jquery.jgrowl.min.js"
			type="text/javascript"></script>

		<script>
    /*<![CDATA[*/
    	var articleId = 23420;
        $(document).ready(function () {
        	$(".rightsReservedCrossref").html((new Date()).getFullYear()-1);
        	        	
        	$("html, body").animate({"scrollTop":$("#titleId").offset().top}, 1000); 
        	
        	if(!Cookies.get('spandidos-gdpr')) {
        	 $('#navbar').show();
    		
        	$(window).scroll(function() {
          		 if($(window).scrollTop() + $(window).height() > $(document).height() - 50) {
          			 $('#navbar').hide();
          		   }
          		 if($(window).scrollTop() + $(window).height() <= $(document).height() - 50) {
          			 $('#navbar').show();
          		   }
          		});
    		 }
        	
            /* citation */
            
            $('#citation').on('click', '.citedBy', function (e) {
                e.preventDefault();
				if ($('#citations').html() != "") {
	                $("#citationDiv").show();				
				}
            });
            
            $('#citationAllArticlesId').on('click', '.citedBy', function (e) {
                e.preventDefault();
				if ($('#citations').html() != "") {
	                $("#citationDiv").show();				
				}
            });
            
            
            var urlTotalCount = $(".citedByCountId").attr('href');
            $.ajax({url: urlTotalCount, cache: false, success: function (result) {

	                if (result) {
	                	
	                	var count = result;
	                	
	                	if (count > 0) {
		                    $("#citationDiv").hide();
	    	                //$("#citations").html(result);
	        	        } else {
	        	        	$("#citedByIdViewArticles").text("No Articles");
	        	        }
	                	$("#citationCount").html(count);
	                	makeCitationsVisible();
	                } else {
	                	$("#citationCount").html(0);
	                	$("#citedByIdViewArticles").text("No Articles");
	                }
            	}

            });
            
            var url = $(".citedBy").attr('href');
            $.ajax({url: url, cache: false, success: function (result) {

                if (result) {
                	var items = $(result).children();
                	var count = items.length;
                	if (count > 0) {
	                    $("#citationDiv").hide();
    	                $("#citations").html(result);
    	                
    	                $("#citedByIdViewArticles").text("View Articles"); 
    	                
        	        }
                	
                	
                	//$("#citationCount").html(count);
                	makeCitationsVisible();
	                } else {
	                	//$("#citationCount").html(0);
	                	 $("#citedByIdViewArticles").text("No Articles"); 
	                }
            	}
            
            
            
            
            }); 
       
            
           var urlMoreLikeThis = $(".moreLikeThis").attr('href');
            $.ajax({url: urlMoreLikeThis, cache: false,success: function(result){
            	$("#moreLikeThisDiv .moreLikeThisClassFragment").html( $("#moreLikeThisUl", result) );   
		    }});

            /* Simple image gallery. Uses default settings */
            $('a.fancybox').fancybox({
                maxWidth: 1000,
                maxHeight: 800,
                helpers: {
                    title: {
                        type: 'inside'
                    }
                }
            });
        });
        
	var doi= $("#doid").val().split("/")[1];
	     	 $.ajax({
        	    type: "GET",
        	    url: "/retrieveArticleDownloadsAndViews/" +  doi, 
        	    dataType: "json",
        	    success: function(data, textStatus, jqXHR) {
        	   
       
        	    if (data!=null) {	    			
	    		  $("#postFullArticleViews").html(data.fullTextCount);
	    		  $("#postArticleDownloads").html(data.pdfCount);
	   			  $("#postPMCFullArticleViews").html(data.pmcFullTextCount);
	   			  $("#postArticlePMCDownloads").html(data.pmcPdfCount);
	   			  $("#postTotalFullArticleViews").html(data.totalFullTextCount);
	   			  $("#postTotalArticleDownloads").html(data.totalPdfCount);
	    	   	}
	    		else  {
	   			  $("#postFullArticleViews").html(0);
	   			  $("#postArticleDownloads").html(0);
	   			  $("#postPMCFullArticleViews").html(0);
	   			  $("#postArticlePMCDownloads").html(0);
	   			  $("#postTotalFullArticleViews").html(0);
	   			  $("#postTotalArticleDownloads").html(0);
	   	      }
		    },
        	   error: function (jqXHR, textStatus, errorThrown) {
		    }
		});
        
	     	 
	    function makeCitationsVisible(){
	    	try{
        		var searchAttribute = $(location).attr('search');
        		if (searchAttribute == '?citations' ) {
        			if ($('#citations').html() != "") {
	                	$("#citationDiv").show();				
					}
        		}
        	} catch (err) {
        		
        	}
	    }
	    
	    $('#toggleSM').click(function() {
	   		 $('.toggleSM').toggle();
		 });
	    
	   
	    $('#toggleSF').click(function() {
	   		 $('.toggleSF').toggle();
		 });
	    
	    
	    
	    $('#toggleMostCitedDimensions').click(function() {
	   		$('.toggleMostCitedDimensions').toggle();
		});
        
        $('#toggleMostCitedCrossRef').click(function() {
	   		$('.toggleMostCitedCrossRef').toggle();
		});
        
        $('#toggleRef').click(function() {
	   		 $('.toggleRef').toggle();
		 });
        
        $('#toggleFig').click(function() {
	   		 $('.toggleFig').toggle();
		 });
        
        var userId= $("#user_id").val();  
        if(userId!='') {
        $.ajax({
    		type: "GET",
   	   		 url: "/retrieveUserSelectedArticle/" + userId +"/" +  doi, 
   	    	dataType: "json",
   	    	success: function(data, textStatus, jqXHR) {
	  		 if (data) {
   				$('#track_citation').css("display", "none"); ;
   				$('#remove_track_citation').css("display", "block");
   	   		 }
   			else  {
   				$('#track_citation').css("display", "block") ;
   				$('#remove_track_citation').css("display", "none");
  	      	}
	   	 	},
   	   		error: function (jqXHR, textStatus, errorThrown) {
	   		 }    	
		});
        } else {
        	$('#track_citation').css("display", "block");
				$('#remove_track_citation').css("display", "none");
        }
        
        $(window).bind("load", function() {
        	var messsageTrackCitation= $('#alert_track_citation_message');	 
        	
        	if(messsageTrackCitation.length>0  && messsageTrackCitation.val()!=null && messsageTrackCitation.val()!='') {	         		
        		$.jGrowl( messsageTrackCitation.val());
        	 }
         });             
              
        /*]]>*/
    </script>


	</div>
	<!-- End Wrapper -->
</body>

</html>